<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78836</article-id><article-id pub-id-type="doi">10.7554/eLife.78836</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-277587"><name><surname>Gutiérrez-Martínez</surname><given-names>Enric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277588"><name><surname>Benet Garrabé</surname><given-names>Susana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-277589"><name><surname>Mateos</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277590"><name><surname>Erkizia</surname><given-names>Itziar</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-277591"><name><surname>Nieto-Garai</surname><given-names>Jon Ander</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8665-099X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277592"><name><surname>Lorizate</surname><given-names>Maier</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184660"><name><surname>Borgman</surname><given-names>Kyra JE</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7898-2911</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-154484"><name><surname>Manzo</surname><given-names>Carlo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8625-0996</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-78054"><name><surname>Campelo</surname><given-names>Felix</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0786-9548</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-23123"><name><surname>Izquierdo-Useros</surname><given-names>Nuria</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1039-1821</contrib-id><email>nizquierdo@irsicaixa.es</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6361"><name><surname>Martinez-Picado</surname><given-names>Javier</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4916-2129</contrib-id><email>jmpicado@irsicaixa.es</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-99774"><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6618-3944</contrib-id><email>maria.garcia-parajo@icfo.eu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03g5ew477</institution-id><institution>ICFO – Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04wxdxa47</institution-id><institution>Lluita contra la sida foundation, Infectious Diseases Department, Hospital Germans Trias i Pujol</institution></institution-wrap><addr-line><named-content content-type="city">Badalona</named-content></addr-line><country>Spain</country></aff><aff id="aff3"><label>3</label><institution>IrsiCaixa AIDS Research Institute</institution><addr-line><named-content content-type="city">Badalona</named-content></addr-line><country>Spain</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/000xsnr85</institution-id><institution>Department of Biochemistry and Molecular Biology, Universidad del País Vasco</institution></institution-wrap><addr-line><named-content content-type="city">Bilbao</named-content></addr-line><country>Spain</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006zjws59</institution-id><institution>Facultat de Ciències i Tecnologia, Universitat de Vic - Universitat Central de Catalunya</institution></institution-wrap><addr-line><named-content content-type="city">Vic</named-content></addr-line><country>Spain</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03bzdww12</institution-id><institution>Germans Trias i Pujol Research Institute (IGTP)</institution></institution-wrap><addr-line><named-content content-type="city">Badalona</named-content></addr-line><country>Spain</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02g87qh62</institution-id><institution>CIBER de enfermedades infecciosas</institution></institution-wrap><addr-line><named-content content-type="city">Madrid</named-content></addr-line><country>Spain</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006zjws59</institution-id><institution>AIDS and Related Illnesses, Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia</institution></institution-wrap><addr-line><named-content content-type="city">Vic</named-content></addr-line><country>Spain</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0371hy230</institution-id><institution>ICREA</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e78836</elocation-id><history><date date-type="received" iso-8601-date="2022-03-22"><day>22</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-19"><day>19</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-04-30"><day>30</day><month>04</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.04.28.489919"/></event></pub-history><permissions><copyright-statement>© 2023, Gutiérrez-Martínez et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Gutiérrez-Martínez et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78836-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78836-figures-v2.pdf"/><abstract><p>The immunoglobulin-like lectin receptor CD169 (Siglec-1) mediates the capture of HIV-1 by activated dendritic cells (DCs) through binding to sialylated ligands. These interactions result in a more efficient virus capture as compared to resting DCs, although the underlying mechanisms are poorly understood. Using a combination of super-resolution microscopy, single-particle tracking and biochemical perturbations we studied the nanoscale organization of Siglec-1 on activated DCs and its impact on viral capture and its trafficking to a single viral-containing compartment. We found that activation of DCs leads to Siglec-1 basal nanoclustering at specific plasma membrane regions where receptor diffusion is constrained by Rho-ROCK activation and formin-dependent actin polymerization. Using liposomes with varying ganglioside concentrations, we further demonstrate that Siglec-1 nanoclustering enhances the receptor avidity to limiting concentrations of gangliosides carrying sialic ligands. Binding to either HIV-1 particles or ganglioside-bearing liposomes lead to enhanced Siglec-1 nanoclustering and global actin rearrangements characterized by a drop in RhoA activity, facilitating the final accumulation of viral particles in a single sac-like compartment. Overall, our work provides new insights on the role of the actin machinery of activated DCs in regulating the formation of basal Siglec-1 nanoclustering, being decisive for the capture and actin-dependent trafficking of HIV-1 into the virus-containing compartment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>actin cytoskeleton</kwd><kwd>receptor nanoclustering</kwd><kwd>super-resolution microscopy</kwd><kwd>single-particle tracking</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>788546</award-id><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>754558</award-id><principal-award-recipient><name><surname>Mateos</surname><given-names>Nicolas</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>CEX2019-000910-S</award-id><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>PID2020-113068RB-I00 / 10.13039/501100011033</award-id><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>PID2019-109870RB-I00</award-id><principal-award-recipient><name><surname>Martinez-Picado</surname><given-names>Javier</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>PID2020-117405GB-100</award-id><principal-award-recipient><name><surname>Lorizate</surname><given-names>Maier</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>RYC-2017-22227</award-id><principal-award-recipient><name><surname>Campelo</surname><given-names>Felix</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>RYC-2015-17896</award-id><principal-award-recipient><name><surname>Manzo</surname><given-names>Carlo</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>PID2019-106232RB-I00/10.13039/501100011033</award-id><principal-award-recipient><name><surname>Campelo</surname><given-names>Felix</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>PID2020-117145RB-I00</award-id><principal-award-recipient><name><surname>Izquierdo-Useros</surname><given-names>Nuria</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002809</institution-id><institution>Generalitat de Catalunya</institution></institution-wrap></funding-source><award-id>2017SGR1000</award-id><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>FUNDACIÓ Privada MIR-PUIG</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008050</institution-id><institution>Fundación Cellex</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Garcia-Parajo</surname><given-names>Maria F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Advanced imaging methods reveal that Siglec-1 spatial distribution on mature dendritic cells is regulated by components of the actin polymerization machinery impacting on its engagement to HIV-particles and virus sequestration toward virus-containing compartments.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Dendritic cells (DCs) are a specialized group of leukocytes that play an essential role in the innate and adaptive immunity through their function as antigen presenting cells (<xref ref-type="bibr" rid="bib4">Banchereau and Steinman, 1998</xref>). DCs patrol peripheral tissues capturing invading pathogens, including viruses such as HIV-1, which are then degraded into antigens as the cells migrate toward the lymph nodes to activate T-cell responses. However, HIV-1 can also exploit DCs as vehicles to <italic>trans</italic>-infect CD4<sup>+</sup> T cells, a process that allows the dissemination of the virus through cell-to-cell contacts (<xref ref-type="bibr" rid="bib14">Cameron et al., 1992b</xref>; <xref ref-type="bibr" rid="bib66">Pope et al., 1994</xref>). Although iDCs express receptors and co-receptors required for HIV-1 infection (<xref ref-type="bibr" rid="bib30">Granelli-Piperno et al., 1996</xref>; <xref ref-type="bibr" rid="bib86">Turville et al., 2002</xref>), their infection rates in culture are lower than the ones for activated CD4<sup>+</sup> T cells or macrophages (<xref ref-type="bibr" rid="bib13">Cameron et al., 1992a</xref>; <xref ref-type="bibr" rid="bib31">Granelli-Piperno et al., 1998</xref>; <xref ref-type="bibr" rid="bib32">Granelli-Piperno et al., 1999</xref>; <xref ref-type="bibr" rid="bib67">Pope et al., 1995</xref>). Moreover, iDCs direct part of the trapped viruses to the endolysosomal degradation pathway, which further decreases both the susceptibility of iDCs to infection and the load of viral particles that reach the cytoplasm to initiate their intracellular replication (<xref ref-type="bibr" rid="bib87">Turville et al., 2004</xref>). As such, iDCs are inefficient <italic>trans</italic>-infecting T cells. In strong contrast, activation of DCs by lipopolysaccharide (LPS) or interferon (IFN), which are immunomodulatory signals present during HIV-1 infection, diminishes their susceptibility to infection but significantly increases the capture of HIV-1 and enhances the <italic>trans</italic>-infection of CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib37">Izquierdo-Useros et al., 2007</xref>; <xref ref-type="bibr" rid="bib92">Wang et al., 2007</xref>).</p><p>The immunoglobulin-like lectin receptor CD169 (Siglec-1) is a key molecule in the HIV-1 capture and <italic>trans</italic>-infection of T cells by activated DCs (<xref ref-type="bibr" rid="bib40">Izquierdo-Useros et al., 2012b</xref>; <xref ref-type="bibr" rid="bib69">Puryear et al., 2013</xref>). Siglec-1 is a type I transmembrane protein that contains an amino-terminal V-set domain, which can directly bind to sialylated ligands like the ones present in gangliosides of the HIV-1 membrane (<xref ref-type="bibr" rid="bib17">Crocker et al., 2007</xref>). In LPS-activated DCs (i.e., mature DCs, mDCs), once HIV-1 engages Siglec-1, a large amount of viral particles accumulate in a compartment connected to the extracellular milieu and enriched in several tetraspanin proteins (<xref ref-type="bibr" rid="bib27">Garcia et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Hyun et al., 2008</xref>; <xref ref-type="bibr" rid="bib38">Izquierdo-Useros et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Izquierdo-Useros et al., 2012b</xref>; <xref ref-type="bibr" rid="bib69">Puryear et al., 2013</xref>). The formation of this virus-containing compartment (VCC) reduces HIV-1 endolysosomal degradation while the accumulation of viruses enhances the viral load to <italic>trans</italic>-infect T cells (<xref ref-type="bibr" rid="bib40">Izquierdo-Useros et al., 2012b</xref>).</p><p>Activation of DCs by LPS or IFNα upregulates the expression levels of Siglec-1, which partially explains their higher HIV-1 capture ability as compared to iDCs (<xref ref-type="bibr" rid="bib1">Akiyama et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Izquierdo-Useros et al., 2012b</xref>). However, multiple studies indicate that the spatial organization of plasma membrane receptors in immune cells as well as structural characteristics of their ligands also play an important role in the regulation of ligand/receptor interactions (<xref ref-type="bibr" rid="bib12">Cambi et al., 2004</xref>; <xref ref-type="bibr" rid="bib18">de Bakker et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Gold and Reth, 2019</xref>; <xref ref-type="bibr" rid="bib60">Neumann et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Sherman et al., 2011</xref>; <xref ref-type="bibr" rid="bib84">Torreno-Pina et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Torreno-Pina et al., 2014</xref>). For instance, the C-type lectin DC-specific intercellular adhesion molecule grabbing non-integrin (DC-SIGN), which also mediates the capture and internalization of several pathogens, including HIV-1 (<xref ref-type="bibr" rid="bib48">Kwon et al., 2002</xref>), organizes in small nanoclusters in the plasma membrane of iDCs (<xref ref-type="bibr" rid="bib12">Cambi et al., 2004</xref>; <xref ref-type="bibr" rid="bib18">de Bakker et al., 2007</xref>). Such confined distribution increases the avidity of DC-SIGN for multimeric ligands by providing docking nano-platforms particularly efficient for the capture, internalization and degradation of viral particles (<xref ref-type="bibr" rid="bib12">Cambi et al., 2004</xref>). Recently, another study established a link between the physical properties of synthetic glycopolymers carrying the mannose ligands for DC-SIGN and the internalization rates of the receptor (<xref ref-type="bibr" rid="bib41">Jarvis et al., 2019</xref>). Longer polymers with a higher number of mannose copies internalize faster than shorter ones, and polymer aggregation in the surface of particulate antigens diverge DC-SIGN receptors from endocytosis, directing them to invaginated pockets similar to the VCC harboring HIV-1 (<xref ref-type="bibr" rid="bib41">Jarvis et al., 2019</xref>). In the context of Siglec-1, artificial liposomes carrying the ganglioside GM4, which contains a sialic acid moiety bound to a single galactose, are barely captured by mDCs (<xref ref-type="bibr" rid="bib39">Izquierdo-Useros et al., 2012a</xref>). In contrast, liposomes with GM1, GM2, or GM3, whose sialic acid is bound to a lactose head group, efficiently bind to Siglec-1 with different concentration-dependent rates (<xref ref-type="bibr" rid="bib39">Izquierdo-Useros et al., 2012a</xref>; <xref ref-type="bibr" rid="bib68">Puryear et al., 2012</xref>). Overall, these findings indicate that the final outcome of viral capture and intracellular trafficking is the combined result of, on the one hand, expression levels and nanoscale organization of the receptors and, on the other hand, concentration, spatial distribution, and intrinsic structural properties of the ligands.</p><p>Here, we used a combination of super-resolution stimulated emission depletion (STED) microscopy and single-particle tracking (SPT) approaches to unravel the role of Siglec-1 nanoscale organization in the capture and trafficking of HIV-1 toward the VCC on activated DCs. Overall, our work reveals that distinctive components of the activated DC actin machinery regulate in a synergistic fashion the different stages of viral capture, trafficking and VCC formation, providing activated DCs with an increased capacity to <italic>trans</italic>-infect T cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>DC activation induces the formation of Siglec-1 nanoclusters with decreased mobility</title><p>The <italic>trans</italic>-infection capacity of DCs correlates with the expression levels of Siglec-1, which are increased upon cell activation with LPS or IFN (<xref ref-type="bibr" rid="bib40">Izquierdo-Useros et al., 2012b</xref>; <xref ref-type="bibr" rid="bib69">Puryear et al., 2013</xref>). However, the spatial organization of Siglec-1 receptors in resting or activated DCs is not yet known. To address whether DC maturation alters Siglec-1 distribution in the plasma membrane, we first examined the nanoscale organization of Siglec-1 by STED microscopy in iDCs and LPS-treated DCs (mDCs) differentiated from peripheral blood monocytes (PBMCs) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). With a lateral resolution of ~80 nm (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), we discriminated individual Siglec-1 fluorescent spots on the cell surface and measured their peak intensities. To quantify the number of Siglec-1 molecules per spot in the plasma membrane of iDC and mDC we relied on the intensity obtained from individual antibodies (Abs) on glass, corresponding to single molecules (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B–D</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>; <xref ref-type="bibr" rid="bib57">Martínez-Muñoz et al., 2018</xref>). LPS-mediated DC maturation induced a higher fraction (~57% vs. ~37%) of Siglec-1 dimers and small nanoclusters with &gt;3 molecules/spot as compared to iDCs, where Siglec-1 was mainly found as monomers (~57% vs. ~22%) (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). The increase in the average number of molecules per spot also coincided with an average increase in spot sizes (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>) and a significant increase in the proximity of Siglec-1 spots on mDCs as compared to iDCs (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). To exclude any potential artifacts associated to the labeling strategy and/or fixation protocol, we performed STED imaging using single-chain Abs (instead of full Abs) on mDCs fixed either with 4% paraformaldehyde (PFA) or with 1% PFA + 0.2% glutaraldehyde (GA). Analysis of multiple STED images using single-chain Abs showed no difference in terms of nanoclustering capacity of Siglec-1 on mDCs as compared to full Ab labeling, regardless of the fixation method (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–I</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>). Thus, these controls safely exclude any potential perturbation induced by the Abs. or cell fixation on the nanoclustering degree of Siglec-1.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Dendritic cell (DC) activation induces the formation of Siglec-1 nanoclusters with decreased mobility.</title><p>(<bold>A</bold>) Representative STED images of Siglec-1 in immature DCs (iDCs) and mature DCs (mDCs). The pseudo-color code denotes the intensity of individual Siglec-1-labeled spots, from monomer (dark blue) to nanocluster (red-to-white). The insets show enlarged regions highlighted by the white boxes on the main images (scale bar: 1 µm). Siglec-1 has been labeled using full Abs (see Materials and methods). Control experiments using single-chain Abs and different fixation methods are shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–I</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>, and <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>. (<bold>B</bold>) Frequency of the number of Siglec-1 molecules per spot, in iDC and mDC. Bars represent the mean ± standard error of the mean (SEM) of 3 different donors (minimum of 9 cells/donor and condition). (<bold>C</bold>) Average size of Siglec-1 spots and (<bold>D</bold>) proximity between individual spots, calculated by measuring the nearest neighbor distance (NND) between spots per cell, in iDC and mDC. Each symbol in (<bold>C, D</bold>) corresponds to an individual cell, red lines are the average value on iDCs and mDCs for each donor (4 donors, 9 cells/donor and cell type). (<bold>E</bold>) Representative Siglec-1 trajectories with the receptor labeled with single-chain Abs at sub-labeling conditions as recorded on an iDC (left) and an mDC (right). The magnified insets show examples of different types of motion as classified by the MSS analysis. (<bold>F</bold>) Frequency of the diffusion coefficients for individual Siglec-1 trajectories on iDCs and mDCs. The dash vertical line corresponds to the diffusion threshold to separate immobile from mobile particles (0.002 µm<sup>2</sup>/s). Each data set represents the mean ± SEM of 3 donors (minimum of 3 cells and 83 trajectories/cell). (<bold>G</bold>) Fraction of immobile trajectories (&lt;0.002 μm<sup>2</sup>/s). Each symbol corresponds to an individual cell, red lines are the average value on iDCs and mDCs for each donor (3 donors). (<bold>H</bold>) Fraction of mobile trajectories (&gt;0.002 μm<sup>2</sup>/s) classified as confined, sub-diffusive or free. Each symbol corresponds to an individual cell, red lines show the average value on iDCs and mDCs for 3 donors analyzed. (<bold>I</bold>) Plots showing the center of mass of individual Siglec-1 trajectories (average <italic>x</italic>,<italic>y</italic> position in all the frames of a given trajectory) in iDC and mDC. Blue dots correspond to immobile and confined trajectories, and red dots correspond to sub-diffusive and free trajectories. The graph shows all the trajectories analyzed for a minimum of 8 cells per condition from one donor. (<bold>J</bold>) Distance from the cell center of immobile/confined (black squares) and sub-diffusive/free (empty circles) trajectories in iDC and mDC. Black squares are paired to the empty circles within the same cell. Red symbols correspond to the average values of a minimum of 3 iDC and mDC cells per donor (3 donors). ns, p &gt; R 0.05, * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig1">Figure 1B–D, G, H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Different nanoscale distribution of Siglec-1 in immature versus mature DCs.</title><p>(<bold>A</bold>) STED images of Siglec-1 antibodies non-specifically adhered to glass and labeled with Fab-Atto488 secondary antibodies with a corresponding Gaussian fit of the intensity (left); and representative STED images of Siglec-1 on immature dendritic cells (iDCs) and mature dendritic cells (mDCs) together with enlarged views. Scale bars in the enlarged views are 1μm (<bold>B</bold>) Histogram of the spot intensities for Siglec-1 antibodies adhered on glass. The black line (and shaded region) shows the lognormal fit of the experimental data, and the dashed lines correspond to the calculated intensity distribution functions for different numbers of molecules per spot. Intensity distributions of Siglec-1 spots from the representative images of iDC (<bold>C</bold>) and mDC (<bold>D</bold>). Black lines are the fit of experimental intensity distributions from which we extract the probability of having 1 up to &gt;4 molecules/spot (see bar graphs in the insets). (<bold>E</bold>) Representative Coomassie-stained NuPAGE gel showing the generation of single-chain antibodies from a mouse monoclonal [Hsn 7D2] anti-Siglec-1 antibody. Full (lanes 1 and 3) and single-chain antibodies (lanes 2 and 4) that were either left untreated (not denatured; lanes 1 and 2) or reduced with beta-mercaptoethanol (denatured; lanes 3 and 4) were loaded in the gel, as denoted. Representative STED images of Siglec-1 in mDCs fixed using 4% paraformaldehyde (PFA) (<bold>F, G</bold>) or 1% PFA + 0.2% glutaraldehyde (GA) (<bold>H</bold>) and labeled using the full length anti-Siglec-1 antibody (<bold>F</bold>) or the single-chain Siglec-1 antibody (<bold>G, H</bold>). The pseudo-color code denotes the intensity of individual Siglec-1-labeled spots, from monomer (dark blue) to nanocluster (red-to-white). The insets show enlarged regions highlighted by the white dashed boxes on the main images (scale bars are 5 μm in the main images and 1 μm in the zoomed-in panels). (<bold>I</bold>) Frequency of the number of Siglec-1 molecules per spot in mDCs corresponding to panels (<bold>F–H</bold>). Bars represent the mean ± standard error of the mean (SEM) of at least 2 different donors (minimum of 3 cells/donor and condition). (<bold>J</bold>) In silico spots generated with an Full-width-at-half-maximum (FWHM) as extracted from the experimental data shown in panel A for spots on glass (left), Siglec-1 staining in iDC (middle), and mDC (right). To generate the in silico images we quantified the total number of Siglec-1 receptors by taking into account the number of molecules per spot and total number of spots. The resulting number of molecules was randomly distributed within the cell area as spots that were convoluted with the FWHM of experimental data (60–80 nm). Average area of Siglec-1 spots per cell (<bold>K</bold>), average nearest neighbor distance (NND) between Siglec-1 spots per cell (<bold>L</bold>), and average number of molecules per spot per cell (<bold>M</bold>), in iDC and mDC. For each cell analyzed the values are normalized to the respective in silico values of Siglec-1 random distributions (mean + standard deviation [SD] of one representative experiment; <italic>N</italic> = 3). * p&lt; % 0.05, *** &lt; p % 0.0001.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Zip folder containing the uncropped gel shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref> with the relevant bands clearly labeled.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig1-figsupp1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Excel file containing the source data for panels I, K–M.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig1-figsupp1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To rule out that nanoclustering and their spatial proximity were simply a consequence of the increased expression of Siglec-1 upon DC maturation, we performed simulations of spots randomly distributed through the cell area using identical Siglec-1 molecular densities as obtained from the experimental data (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>). Interestingly, normalization of the experimental data to the randomized values preserved the significant differences between mDC and iDC in spot size, proximity between spots and number of molecules per spot (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K–M</xref> and <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>). Thus, these results indicate the existence of real, active basal nanoclustering of Siglec-1 after DC maturation.</p><p>The differences in Siglec-1 nanoscale organization between iDC and mDC might result from a difference in receptor mobility in the plasma membrane (<xref ref-type="bibr" rid="bib57">Martínez-Muñoz et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Torreno-Pina et al., 2016</xref>). To characterize the mobility of Siglec-1 we performed single-particle tracking (SPT) of individual Siglec-1 molecules labeled at low density using an anti-mouse Fab fragment conjugated to Atto488. Albeit different types of mobility were observed on both cell types (representative tracks in <xref ref-type="fig" rid="fig1">Figure 1E</xref>), DC maturation led to an overall reduction of Siglec-1 diffusion (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) and increased the fraction of immobile receptors (diffusion values &lt;0.002 μm<sup>2</sup>/s), as compared to iDCs (~28% vs. ~48%) (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). We further used the momentum scaling spectrum (MSS) analysis to classify the type of motion of the mobile trajectories (<xref ref-type="bibr" rid="bib25">Ferrari et al., 2001</xref>; <xref ref-type="bibr" rid="bib74">Sbalzarini and Koumoutsakos, 2005</xref>). We found a significant increase in the fraction of confined trajectories on mDCs as compared to iDC (~47% vs. ~35%), and no differences in the fraction of free mobile trajectories between both cell types (<xref ref-type="fig" rid="fig1">Figure 1H</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Moreover, immobile and/or confined trajectories in mDC were preferentially located close to the cell edges (<xref ref-type="fig" rid="fig1">Figure 1I, J</xref>) as compared to the more even distribution observed in iDC, suggesting that upon DC activation Siglec-1 diffusion becomes spatially constrained in specific regions of the plasma membrane. Altogether, these results indicate that LPS activation of DCs not only increases Siglec-1 expression, but importantly, it also modulates its nanoclustering, lateral mobility, and overall spatial distribution on the plasma membrane.</p></sec><sec id="s2-2"><title>Formin-dependent actin polymerization regulates Siglec-1 nanoscale organization and mobility</title><p>Previous studies have demonstrated an essential role for the actin cytoskeleton modulating the capture of HIV-1 and the formation of the VCC by mDCs (<xref ref-type="bibr" rid="bib38">Izquierdo-Useros et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Ménager and Littman, 2016</xref>). Although Siglec-1 does not have known intracellular motifs of actin interaction (<xref ref-type="bibr" rid="bib7">Bornhöfft et al., 2018</xref>), it has been documented that the actin cytoskeleton can regulate the nanoscale organization of different membrane receptors, and even lipids, that do not directly bind to actin (<xref ref-type="bibr" rid="bib26">Freeman et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Kusumi et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Rottner et al., 2017</xref>). To assess the role of actin in the spatial organization of Siglec-1, we performed dual color STED imaging of Siglec-1 together with actin in iDCs and mDCs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). When we traced the intensity distributions of actin and Siglec-1 from the cell center we observed a good spatial correlation of both markers in iDC and mDC (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). However, consistent with our previous analysis showing the preferential distribution of confined Siglec-1 molecules close to the cell edges, Siglec-1 and actin were highly enriched near the edges of mDC as compared to iDC, suggesting a role for actin in the regulation of Siglec-1 nanoclustering and its spatial confinement.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Formin-dependent actin polymerization regulates Siglec-1 nanoscale organization and mobility.</title><p>(<bold>A</bold>) Representative dual color STED images of immature dendritic cell (iDC; left) and mature dendritic cell (mDC; right) stained with Siglec-1 and actin (labeled with SiR-actin). Insets show magnified areas with pseudo-color-coded intensities of Siglec-1 (upper), actin (middle), and merged image (lower) (scale bar: 1 µm). (<bold>B</bold>) Siglec-1 and actin intensity from the cell center toward the edge expressed as percentage of total intensity for each marker in iDC and mDC. Lines represent the mean ± standard error of the mean (SEM) of 3 different donors (minimum of 9 cells/donor and condition). (<bold>C</bold>) Representative STED images of mDC stained for Siglec-1 and actin, together with enlarged insets, in control conditions and after 1-hr treatment with CK666 (100 µM) or SMIFH2 (25 µM). The white lines in the insets delimit the Voronoi areas between adjacent Siglec-1 spots; the smaller the areas, the closer single Siglec-1 spots reside from each other (scale bars insets: 1 µm). Siglec-1 and actin intensity from the cell center toward the edge expressed as percentage of total intensity for each marker in control mDC and treated with CK666 (<bold>D</bold>) or SMIFH2 (<bold>E</bold>). Lines represent the mean ± SEM of 2 (<bold>D</bold>) and 4 (<bold>E</bold>) different donors (minimum 10 cells/donor and condition). (<bold>F</bold>) Average Voronoi areas between contiguous Siglec-1 spots per cell in control and CK666-treated cells (2 donors, at least 10 cells/donor). Red lines connect the average of all the cells in each donor. (<bold>G</bold>) Similar to (<bold>F</bold>) for control and SMIFH2-treated cells (3 donors, at least 10 cells/donor). (<bold>H</bold>) Frequency histogram of the number of Siglec-1 molecules per spot in control and CK666-treated mDC. Mean ± SEM of a minimum of 10 cells/donor from 2 donors. (<bold>I</bold>) Similar to (<bold>H</bold>) for control and SMIFH2-treated cells (3 donors, at least 10 cells/donor). (<bold>J</bold>) Frequency of Siglec-1 diffusion coefficients in control mDC (<italic>n</italic> = 8 cells, 4424 trajectories) and cells treated with SMIFH (<italic>n</italic> = 8 cells, 5002 trajectories) from one donor. (<bold>K</bold>) Fraction of immobile trajectories in control and SMIFH2-treated mDCs. A total of 21 (control) and 24 (SMIFH2) cells were quantified from 3 donors (minimum 6 cells and 1261 trajectories/donor and condition). Red lines connect the average of each individual donor. (<bold>L</bold>) Fraction of mobile trajectories classified as confined, sub-diffusive or free in control and SMIFH2-treated mDC. Each symbol corresponds to an individual cell, red lines show the average value of all cells from 3 donors (minimum 6 cells/donor and condition). ns, p &gt; R 0.05, * p &lt; % 0.05, *** p &lt; % 0.0001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig2">Figure 2B, D–L</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Formin-dependent actin polymerization regulates Siglec-1 nanoscale organization and mobility.</title><p>(<bold>A</bold>) Representative dual color STED images of mature dendritic cell (mDC) stained with Siglec-1 and SiR-actin in control conditions and after 1-hr treatment with Cytochalasin D (Cyto D, 2 µg/ml). The bottom panels correspond to magnified images of the dashed squares (scale bars: 2 µm). (<bold>B</bold>) Siglec-1 and actin intensity from the cell center toward the edge expressed as percentage of total intensity for each marker in immature dendritic cell (iDC) control mDC and cells treated with Cyto D. Lines represent the mean + standard error of the mean (SEM) of two different donors in which a minimum of 10 cells/donor and condition were analyzed. (<bold>C</bold>) Frequency histogram of the number of Siglec-1 molecules per spot in control mDCs and cells treated with Cyto D. Mean + SEM of a minimum of 9 cells/donor from two donors. (<bold>D</bold>) Plots showing the center mass of individual Siglec-1 trajectories (average <italic>x</italic>,<italic>y</italic> position in all the frames of a trajectory) in control mDC and cells treated with SMIFH2, colored-coded according to their mobility. The graph shows the centers of all the trajectories analyzed for a minimum of 8 cells per condition from one representative experiment (<italic>N</italic> = 3). (<bold>E</bold>) Distance from the cell center of immobile/confined and sub-diffusive/free trajectories in control mDC and cells treated with SMIFH2. Black squares show the average distance from the cell center of all immobile/confined trajectories in one cell, and are paired to the average values of all sub-diffusive/free trajectories within the same cell (empty circles). (<bold>F</bold>) Representative STED image of a mDC fixed and stained for Siglec-1 and SiR-actin after injection between a glass coverslip and a layer of agarose with CCL19 at 2.5 µg/ml. The rose plot histogram shows the distribution of Siglec-1 staining from rear to front in 40° bins. On the bottom magnified insets of Siglec-1 and actin at the rear and the front of the cell (scale bar: 2 µm). (<bold>G, H</bold>) Rose plot histograms of actin and Siglec-1 intensity distributions on the front and rear end of mDCs subjected to a CCL19 homogeneous gradient in an under-agarose assay. Graphs show the mean + SEM (red lines) of two donors with a minimum of 10 cells/donor. (<bold>I</bold>) Frequency histogram of the number of Siglec-1 molecules per spot at the rear and the front of mDCs treated as in G. Mean + SEM of a minimum of 10 cells/donor from two donors. ns, p &gt; R 0.05, * p &lt; % 0.05, ** p &lt; % 0.001; *** p&lt; % 0.0001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Excel file containing the source data for panels B, C, E, I.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig2-figsupp1-v2.tif"/></fig></fig-group><p>To further test this hypothesis, we first treated mDCs with Cytochalasin D (CytoD), a drug that inhibits actin polymerization. In these conditions, Siglec-1 staining dispersed throughout the plasma membrane (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B</xref> and <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>) and the fraction of Siglec-1 receptors found in dimers or small nanoclusters decreased in favor of a significant increase of monomers (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref> and <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>). Because cortical actin mainly depends on two different polymerization mechanisms, one Arp2/3 dependent which forms branched actin, and another dependent on formins which produce filamentous actin bundles (<xref ref-type="bibr" rid="bib70">Rottner et al., 2017</xref>), we selectively inhibited each of these mechanisms using CK666 (Arp2/3 inhibitor) or SMIFH2 (formin inhibitor) in mDCs (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The association of Siglec-1 high-density regions with cortical actin near the cell edges was not affected by Arp2/3 inhibition, but decreased when we inhibited formins (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Such dispersion was further quantified using a tessellation-based analysis to define areas between adjacent Siglec-1 spots (the smaller the areas, the higher the density). Whereas Arp2/3 inhibition did not affect the proximity between Siglec-1 spots (<xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), formin inhibition significantly increased the separation between individual spots consistent with their spatial dispersion (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Importantly, formin inhibition, but not Arp2/3 inhibition, reduced the basal Siglec-1 nanoclustering as compared to control conditions (<xref ref-type="fig" rid="fig2">Figure 2H, I</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>).</p><p>These results indicate that Siglec-1 nanoclustering in activated DCs relies on a formin-dependent actin polymerization mechanism of confinement. These findings were further substantiated by SPT analysis. Although the mobile fraction of Siglec-1 (above 0.002 µm<sup>2</sup>/s) did not show significant differences in the diffusion coefficients (<xref ref-type="fig" rid="fig2">Figure 2J</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), we observed a significant decrease in the fraction of immobile and confined trajectories upon formin inhibition (<xref ref-type="fig" rid="fig2">Figure 2K, L</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Moreover, consistent with the dissociation of Siglec-1 from the regions enriched in cortical actin, formin inhibition also led to a more even distribution of immobile and mobile Siglec-1 receptors through the cell area (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E</xref>).</p><p>To further demonstrate the relationship between formins and Siglec-1 nanoscale organization, we measured Siglec-1 distribution in a physiological situation in which different types of actin pools simultaneously occur at specific regions of the plasma membrane. Activated DCs in confined environments, when subjected to chemokine stimuli, migrate in a process that requires actin polarization at the leading edge (mainly dependent on Arp2/3 branched actin) and at the cell rear (formin-dependent filamentous actin) (<xref ref-type="bibr" rid="bib42">Jolly et al., 2007</xref>; <xref ref-type="bibr" rid="bib49">Lämmermann et al., 2009a</xref>; <xref ref-type="bibr" rid="bib64">Paluch et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Vargas et al., 2016</xref>). We thus squeezed activated DCs between a layer of agarose and a coverslip with a homogeneous concentration of the chemokine CCL19, and subsequently fixed and stained the cells for Siglec-1 and actin. The spatial constrain of mDCs in this semi-3D environment was optimal to observe in the same plane a clear polarization of a protrusive lamellipodium and a contractile trailing edge (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Whereas actin staining was isotropic at the front and cell rear (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>), Siglec-1 was remarkably enriched at the formin-dependent trailing edge (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>). Moreover, a significant enhancement of Siglec-1 nanoclusters was detected at the trailing edge as compared to the lamellipodium at the front (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I</xref> and <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>). Collectively, these results indicate that formin-dependent cortical actin regulates the nanoscale organization, membrane lateral confinement and diffusion of Siglec-1 in activated DCs.</p></sec><sec id="s2-3"><title>Siglec-1 confinement and nanoclustering occurs in polarized regions of the plasma membrane characterized by RhoA activity</title><p>The previous results suggest differences in the organization of the actin cytoskeleton between mDCs and iDCs, which might impact on the overall spatiotemporal organization of Siglec-1. Recent studies have shown that DC maturation increases Rho activity in polarized regions of the membrane, which in turn enhances formin-dependent actin polymerization in filamentous bundles (<xref ref-type="bibr" rid="bib89">Vargas et al., 2016</xref>). Thus, to assess the existence of a basal polarization of different actin polymerization mechanisms regulating the confinement of Siglec-1, we first imaged the distribution of Siglec-1 together with actin and the phosphorylated form of ezrin–radixin–moesin (pERM), a well-known actin-associated marker that becomes activated downstream of RhoA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). As previously reported in LPS-activated macrophages (<xref ref-type="bibr" rid="bib23">Di Pietro et al., 2017</xref>), we detected an increase in the levels of pERM in mDCs as compared to iDCs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>). Most importantly, we observed a clear polarization of Siglec-1 to cell regions closer to the basal membrane in mDCs (i.e., within the first 3–5 μm) (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>), and characterized by the abundance of filopodia enriched in pERM (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Siglec-1 confinement and basal nanoclustering occur in polarized regions of the plasma membrane characterized by RhoA activity.</title><p>(<bold>A</bold>) Representative maximum intensity projections of 3D confocal images of immature dendritic cell (iDC; upper row) and mature dendritic cell (mDC; lower row) immunostained with anti-Siglec-1, SiR-actin, and pERM. Plots of the axial distribution from the cell base of Siglec-1 (<bold>B</bold>) and pERM (<bold>C</bold>) intensities. Values in each plane show the mean intensity in steps of 1.5 µm from the cell base, normalized by the minimum mean intensity within the whole stack. Each symbol represents the mean ± standard error of the mean (SEM) from two donors (at least 10 cells per condition). (<bold>D</bold>) Confocal projections of the basal (0–5 µm) and the apical (&gt;5 µm) parts of the mDC example shown in (<bold>A</bold>). (<bold>E</bold>) Top panels: confocal maximum intensity projections images of control mDC and cells treated for 3 hr with CT04 (2 µg/ml), or for 1 hr with Y-27632 (30 µM), fixed and immunostained with anti-Siglec-1, SiR-actin, and pERM. Middle panels: enlarged images from the highlighted regions of the top images (scale bar: 2 µm). Bottom panels: STED images of mDCs treated as described above and immunostained with anti-Siglec-1. Siglec-1 intensity as function of axial distance from the cell base in control mDC and cells treated with CT04 (<bold>F</bold>) and Y-27623 (<bold>G</bold>). Results show the mean ± standard error of the mean (SEM) of two donors, with at least 7 (<bold>F</bold>) and 9 (<bold>G</bold>) cells/donor and condition. Average Voronoi areas between contiguous Siglec-1 spots in control mDC, and cells treated with CT04 (<bold>H</bold>) and Y-27623 (<bold>I</bold>). Each dot shows the average Voronoi area per cell; results show the average ± SD of one representative experiment (<italic>n</italic> = 2) with a minimum of 16 (<bold>H</bold>) and 14 (<bold>I</bold>) cells. Number of Siglec-1 molecules per spot in control mDCs and cells treated with CT04 (<bold>J</bold>) and Y-27623 (<bold>K</bold>). Mean ± SEM of 2 donors, with a minimum of 10 (<bold>J</bold>) and 9 (<bold>K</bold>) cells/donor. (<bold>L</bold>) Scheme of the different pathways downstream of Rho activation targeted by different inhibitors. Statistics in the legends of panels B, C, F, G correspond to the significance of a two-way analysis of variance (ANOVA) test depending on maturation status (iDC vs. mDC in <bold>A, B</bold>) or treatment control vs. CT04 or Y-27623 in <bold>F</bold>, <bold>G</bold>. * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig3">Figure 3B, C, F–K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Siglec-1 confinement and basal nanoclustering occurs in polarized regions of the plasma membrane characterized by RhoA activity.</title><p>pERM mean intensity values in control immature dendritic cells (iDCs) and control mature dendritic cells (mDCs) (<bold>A</bold>) or mDCs treated with CT04 (<bold>B</bold>) or Y-27623 (<bold>C</bold>). Results show the mean + standard deviation (SD) of one representative experiment (<italic>N</italic> = 2) in which a minimum of 9 (<bold>A</bold>), 7 (<bold>B</bold>), and 10 (<bold>C</bold>) cells/donor and condition were analyzed. (<bold>D</bold>) STED images of the basal plane for control iDCs or cells treated for 3 hr with CN04 (2 µg/ml) and immunostained with anti-Siglec-1, SiR-actin, and pERM. Insets correspond to enlarged images of the regions highlighted in the main images (scale bars: 2 µm). (<bold>E</bold>) pERM mean intensity values in control iDCs and cells treated with CN03. Results show the mean + SD of one representative experiment (<italic>N</italic> = 2) with a minimum of 9 cells/donor and condition. (<bold>F</bold>) Plots of the axial distribution of Siglec-1 intensity in control iDCs and cells treated with CN03 obtained from 3D confocal images (10–15 stacks). Values in each plane show the mean intensity in steps of 1.5 µm from the cell base, normalized by the minimum mean intensity within the whole stack. Each symbol represents the mean + standard error of the mean (SEM) of two donors with at least 9 cells per condition. (<bold>G</bold>) Same as in (<bold>F</bold>) but for pERM intensity. (<bold>H</bold>) Frequency histogram of the number of Siglec-1 molecules per spot in control iDCs and cells treated with CN03. Mean + SEM of two donors, at least 9 cells/donor and condition. (<bold>I</bold>) Confocal maximum intensity projection images of control mDCs and cells treated for 3 hr with NSC668394 (250 µM), or for 1 hr with SMIFH2 (25 µM), immunostained with anti-Siglec-1, SiR-actin, and pERM. Insets correspond to enlarged images of the regions highlighted in the main images. Scale bars: 2 µm. (<bold>J</bold>) pERM mean intensity values in control mDC and cells treated with NSC668394. Mean + SD of a minimum of 8 cells per condition from one representative experiment (<italic>N</italic> = 2). (<bold>K</bold>) Same as in (<bold>F</bold>) but in control mDCs and cells treated with NSC668394. Each symbol represents the mean + SEM of two donors, with at least 9 cells per condition. (<bold>L</bold>) Frequency histogram of the number of Siglec-1 molecules per spot in control mDCs and cells treated with NSC668394. Mean + SEM of two donors, at least 9 cells/donor and condition. (<bold>M</bold>) pERM mean intensity values in control and SMIFH2-treated mDC. Data show the mean + SD of one representative experiment (<italic>N</italic> = 2) with a minimum of 10 cells per condition. (<bold>N</bold>) Same as in (<bold>K</bold>) but in control mDC and cells treated with SMIFH2. Each symbol represents the mean + SEM of two donors, with a minimum of 10 cells per condition. * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Excel file containing the source data for panels B, C, E–H, J–N.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig3-figsupp1-v2.tif"/></fig></fig-group><p>Next, we assessed if Rho activity was involved in the polarized distribution of Siglec-1 in mDCs. Pharmacological inhibition of RhoA (CT04) as well as of its downstream effector, the Rho-associated protein kinase ROCK (Y-27632), decreased the levels of pERM in mDCs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>) and importantly, disrupted the polarized confinement of Siglec-1 in mDCs, resulting in a more even distribution throughout the plasma membrane (<xref ref-type="fig" rid="fig3">Figure 3E–G</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Moreover, RhoA and ROCK inhibition led to a significant decrease in the density of Siglec-1 nanoclusters, as determined by STED (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, bottom panels; <xref ref-type="fig" rid="fig3">Figure 3H, I</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>), and to a reduced basal nanoclustering (<xref ref-type="fig" rid="fig3">Figure 3J, K</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>), with values similar to those measured in iDCs. Significantly, treatment of iDCs with an RhoA activator (CN03), led to an increase of pERM levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D, E</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>), Siglec-1 and pERM polarization in the basal plane of the cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F, G</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>) and induction of basal Siglec-1 nanoclustering (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>) fully mirroring the results obtained on activated DCs. Together, these data strongly indicate that basal nanoclustering of Siglec-1 on activated DCs is the consequence of higher basal levels of RhoA activation, as compared to resting DCs.</p><p>It has been reported that the spatiotemporal organization of several receptors is influenced by the presence of additional membrane receptors that work as pickets in association with pERM (<xref ref-type="bibr" rid="bib26">Freeman et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Kalay et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Kusumi et al., 2012</xref>; <xref ref-type="bibr" rid="bib85">Trimble and Grinstein, 2015</xref>). Given our results, we thus checked the effects of ezrin inhibition in the spatial organization of Siglec-1 on mDCs. Pharmacological inhibition of ERM (NSC668394) led to a significant drop in the levels of pERM (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I, J</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>), significantly disrupted the spatial polarization of Siglec-1 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1K</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>) and reduced Siglec-1 nanoclustering (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>). Notably, formin inhibition did not alter the basal levels of pERM (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1M</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>) but disrupted the polarized distribution of Siglec-1 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1N</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>). Hence, our results strongly indicate that Rho activity in mDCs regulates Siglec-1 basal nanoclustering and its spatial confinement in polarized regions of the plasma membrane through two necessary, but independent mechanisms: formin activation and ROCK-mediated ERM phosphorylation (<xref ref-type="fig" rid="fig3">Figure 3L</xref>).</p></sec><sec id="s2-4"><title>Siglec-1 basal nanoclustering increases the capture of HIV-1 viral-like particles and the avidity to gangliosides carrying sialic acid ligands</title><p>Previous reports have highlighted the importance of nanoscale organization of viral receptors on the capture of viral particles by providing multimolecular docking platforms with high avidity for viral ligands (<xref ref-type="bibr" rid="bib12">Cambi et al., 2004</xref>). To assess the relevance of Siglec-1 nanoscale organization in the capture of HIV-1, we pulsed control, SMIFH2-, or CT04-treated mDCs for 5 min with viral-like particles (VLPs). Inhibition of formin-mediated actin polymerization (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>) or Rho activity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref> and <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>), respectively, which disperse Siglec-1 nanoclustering and its spatial distribution, significantly decreased the immediate binding of VLPs to Siglec-1. Confocal stacks taken from cells immunostained with Siglec-1 without permeabilization revealed no significant differences in the total plasma membrane levels of Siglec-1 in control, SMIFH2-, or CT04-treated cells (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>, and <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>), indicating that receptor availability was not responsible for the decrease in VLP capture. Remarkably, when we analyzed the nanoscale organization of Siglec-1 on 5 min-VLP-pulsed cells, we found that Siglec-1 nanoclusters colocalizing with VLPs had significantly higher number of molecules per spot as compared to non-colocalizing Siglec-1 nanoclusters, in both control and SMIFH2-treated cells (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). These results suggest that both, formin and Rho-dependent Siglec-1 nanoclustering, facilitate the capture of VLPs by providing high-avidity docking platforms to viral ligands.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Siglec-1 basal nanoclustering increases the capture of HIV-1-VLPs and the avidity to gangliosides carrying sialic acid ligands.</title><p>(<bold>A</bold>) Confocal images of control mature dendritic cell (mDC), and cells treated with SMIFH2, pulsed for 5 min with VLP-Gag-Cherry and immunostained with anti-Siglec-1. Insets on the right correspond to enlarged views of the regions highlighted in the main images (scale bars: 2 µm). (<bold>B</bold>) VLP Intensity in control and SMIFH2-treated cells, after 5 min of VLP capture. Mean ± standard deviation (SD) of one representative experiment (<italic>n</italic> = 2) with 14 cells per condition. (<bold>C</bold>) Levels of Siglec-1 in control and SMIFH2-treated cells, after 5 min of VLP capture. Mean ± SD of one representative experiment (<italic>n</italic> = 2), 14 cells per condition. (<bold>D</bold>) Average number of Siglec-1 molecules per spot per cell in control and SMIFH2-treated mDC, at steady state and after 5 min of VLP capture. Siglec-1 data after 5 min VLP exposure are further separated according to whether Siglec-1 spots colocalize (or not) with VLP particles. Data correspond to the mean + SD of one representative experiment (<italic>n</italic> = 3 for the absence of VLP and <italic>n</italic> = 2 for the 5 min VLP) in which a minimum of 8 cells per experiment and condition were analyzed. (<bold>E</bold>) Representative dual color STED images of mDC immunostained with anti-Siglec-1 after 5-min pulse with tRed-LUVs carrying different GM-1 concentrations. Squares are shown as magnified regions in panel (<bold>I</bold>). (<bold>F</bold>) LUV intensity in mDC after 5 min of LUV capture. Mean ± SD of a minimum of 14 cells per condition. (<bold>G</bold>) Sizes of Siglec-1 spots colocalizing with LUVs. Small dots represent each spot analyzed and red squares correspond to the average size of all colocalizing spots in a cell (at least 12 cells per condition). (<bold>H</bold>) Number of Siglec-1 molecules per spot colocalizing with LUVs. Results correspond to the mean ± SD of a minimum of 12 cells per condition. (<bold>I</bold>) Magnified STED images of Siglec-1 colocalizing with LUVs carrying different GM-1 concentrations. Circles with different radii on the Siglec-1 images are drawn starting from the center of each colocalizing spot. (<bold>J</bold>) Siglec-1 density (i.e., number of Siglec-1 molecules per µm<sup>2</sup>) at different radius from Siglec-1 spots colocalizing with 0.25–4% GM-1 LUVs (each small dot is an individual colocalizing spot, red squares are the mean values in each cell analyzed, 12 cells per condition). ns, p &gt; R 0.05, * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig4">Figure 4B–D, F–H, J</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Siglec-1 basal nanoclustering increases the capture of HIV-1-VLPs and the avidity to gangliosides carrying sialic acid ligands.</title><p>(<bold>A</bold>) Confocal images of control mature dendritic cell (mDC), and cells treated with CT04, pulsed for 5 min with VLP-Gag-Cherry and immunostained with anti-Siglec-1. Insets on the right correspond to enlarged views of the regions highlighted in the main images (scale bar: 2 µm). (<bold>B</bold>) VLP Intensity in control and CT04-treated cells, after 5 min of VLP capture. Mean + standard deviation (SD) of one representative experiment (<italic>N</italic> = 2) with 14 cells per condition. (<bold>C</bold>) Levels of Siglec-1 in control and CT04-treated cells, after 5 min of VLP capture. Mean + SD of one representative experiment (<italic>N</italic> = 2) with 14 cells per condition. ns, p &gt; R 0.05, ** p &lt; % 0.001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Excel file containing the source data for panels B, C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig4-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To further substantiate this hypothesis, we generated artificial Large Unilamellar Vesicles (LUVs) (~150 nm in diameter) mimicking the lipid composition of the HIV-1 envelope, but with a gradient of concentrations of the Siglec-1 sialic acid containing ligand GM-1 (from 0.25% to 4%). We pulsed mDCs for 5 min with LUVs and recorded dual color STED images of Siglec-1 and LUVs labeled with texasRed (tRed) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). As expected, the capture of LUVs was strongly dependent on the GM-1 concentration, being highest at 4% GM-1 (<xref ref-type="fig" rid="fig4">Figure 4F</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Remarkably, LUVs with low levels of GM-1 (0.25% and 0.5%) showed a significant preference for binding to larger Siglec-1 nanoclusters and with higher number of molecules per spot, as compared to the LUVs with high GM-1 levels (4%) (<xref ref-type="fig" rid="fig4">Figure 4G, H</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). These data indicate that Siglec-1 clustering contributes to overcome the decrease in ligand availability. Moreover, LUVs preferentially bound to regions with high density of Siglec-1 receptors, an effect that was more pronounced for LUVs carrying low GM-1 levels (<xref ref-type="fig" rid="fig4">Figure 4I, J</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). As a whole, these results indicate that basal Siglec-1 nanoclustering and aggregation in highly dense regions of the membrane constitutes a physical mechanism to increase HIV-1 capture efficiency by increasing the avidity of Siglec-1 receptors to gangliosides carrying sialic acid ligands.</p></sec><sec id="s2-5"><title>Interaction with HIV-1-VLPs induces Siglec-1 changes at the nano- and meso-scale toward the final formation of the VCC</title><p>It is known that initial virus binding in mDCs is followed by a progressive polarized movement of the viruses toward the VCC (<xref ref-type="bibr" rid="bib35">Hyun et al., 2008</xref>; <xref ref-type="bibr" rid="bib38">Izquierdo-Useros et al., 2011</xref>). To enquire if iDC and mDC show differences in the events that occur after initial binding of the virus to Siglec-1, we visualized and compared the spatial evolution of Siglec-1 in iDCs and mDCs at different incubation times with VLPs. After 5 min of VLP capture, only a very modest colocalization of VLPs with Siglec-1 was observed in both iDCs and mDCs being slightly higher in the case of mDCs, (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>). Colocalization progressively increased in time for both types of DCs, but became significantly higher for mDCs at 60 min of VLP incubation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>). This indicates that Siglec-1 is involved in the initial capture of VLPs by DCs regardless of their activation state. Notably, in contrast to iDCs which showed no significant changes in Siglec-1 clustering during the first 30 min of VLP capture (<xref ref-type="fig" rid="fig5">Figure 5A , B</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>), mDCs already exhibited increased Siglec-1 clustering at these times (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). The latter was also accompanied by an increase in the sizes of Siglec-1 spots colocalizing with VLPs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref> and <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>). Moreover, cumulative intensities plots of individual VLPs as a function of distance from their center of mass, showed no changes on iDCs for different capture times (<xref ref-type="fig" rid="fig5">Figure 5E</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>), whereas a significant increase in the proximity, that is, polarization, of VLPs in mDC was observed at 30 min (<xref ref-type="fig" rid="fig5">Figure 5F</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). These results reveal remarkable changes in the nano- and meso-scale organization of Siglec-1 upon VLP capture on mDCs occurring already at early capture times. In contrast, more modest changes are observed on iDCs and are only detected after 60 min of VLP capture.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Interaction with HIV-1 particles induces Siglec-1 changes at the nano- and meso-scale toward the formation of the virus-containing compartment (VCC).</title><p>(<bold>A</bold>) Representative STED images of immature dendritic cell (iDC; left) and mature dendritic cell (mDC; right) immunostained with anti-Siglec-1 after different times of VLP-Gag-Cherry capture. Frequency histograms of Siglec-1 molecules/spot colocalizing with VLP-Gag-Cherry in iDC (<bold>B</bold>) and mDC (<bold>C</bold>) at different times of VLP capture. Mean ± standard deviation (SD) of a minimum of 10 cells per incubation time in iDC and mDC. (<bold>D</bold>) Fold increase in the number of Siglec-1 molecules per spot with respect to the average value at 5 min. Mean ± SD of a minimum of 10 cells per time condition in iDC and mDC. Cumulative frequency plots of VLP particles colocalizing with Siglec-1 as a function of the distance from the VLP intensity center-of-mass, in iDC (<bold>E</bold>) and mDC (<bold>F</bold>) at different times of VLP capture. Dots show the mean ± SD of a minimum of 9 cells per condition and lines show the sigmoidal fit to the data. (<bold>G</bold>) Same as in D, but in mDC incubated for different times with LUVs at 0.5% and 4% GM-1 concentrations. Mean ± SD of a minimum of 13 cells per condition. (<bold>H–I</bold>) Same as in (<bold>E, F</bold>) but in mDCs incubated for different times with 4% (<bold>H</bold>) and 0.5% (<bold>I</bold>) of GM-1. Dots show the mean ± SD of a minimum of 7 cells per time and condition. (<bold>J</bold>) Box plots showing the distance of non-colocalizing spots to colocalizing Siglec-1/VLP spots in mDC for different incubation times. Small dots show the average distance of the whole population of non-colocalizing spots from each Siglec-1/VLP colocalizing spot, and red squares denote the average of all colocalizing spots in an individual cell (at least 9 cells per time). (<bold>K</bold>) Same as in (<bold>J</bold>) but in mDC incubated with 4% and 0.5% GM-1 LUVs (minimum of 11 cells per time and condition). Statistical analysis in the legends of panels (<bold>E, F, H, I</bold>) corresponds to a one-way analysis of variance (ANOVA) comparing the distance from the center-of-mass of VLPs (<bold>E, F</bold>) or LUVs (<bold>H, I</bold>) at which we recover 50% of the total intensity of VLP-Gag-Cherry or LUVs-tRed. ns, p &gt; R 0.05, * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig5">Figure 5B–K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Interaction with HIV-1 particles induces Siglec-1 changes at the nano- and meso-scale towards the formation of the VCC.</title><p>(<bold>A</bold>) Colocalization between Siglec-1 and VLP-Gag-Cherry in immature dendritic cell (iDC) and mature dendritic cell (mDC) after different times of VLP capture as determined by the Pearson coefficient. Mean + standard deviation (SD) of a minimum of 9 cells per condition. (<bold>B</bold>) Size of Siglec-1 spots colocalizing with VLP-Gag-Cherry in iDC and mDC after different times of VLP capture. The average value of all colocalizing spots in each cell after 30 and 60 min of VLP capture is expressed as a fold increase to the average value after a 5-min pulse. Mean + SD of a minimum of 8 per condition. (<bold>C</bold>) Representative STED images of mDC fixed and immunostained with anti-Siglec-1 after different times of incubation with LUVs carrying 4% (upper panels) and 0.5% (lower panels) GM-1. (<bold>D</bold>) Number of Siglec-1 molecules per spot not colocalizing with either VLP, 0.5% or 4% GM-1 LUVs in mDC. Each symbol represents the average value of all non-colocalizing spots in each cell after 30 and 60 min of VLP/LUV addition expressed as a fold increase to the average at 5 min. Mean + SD of a minimum of 10 cells per time and condition. ns, p &gt; R 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Excel file containing the source data for panels A, B, D.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig5-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig5-figsupp1-v2.tif"/></fig></fig-group><p>The fact that VLP polarization occurs concomitantly to the progressive growth of Siglec-1 clusters colocalizing with VLPs on mDCs suggests the possibility that active Siglec-1 clustering, promoted by their interaction with multiple gangliosides carrying sialic ligands in the HIV-1 membrane, regulates the trafficking of the receptor/virus complexes to the VCC. To investigate this scenario, we pulsed mDCs with LUVs carrying low and high GM-1 concentrations, and assessed the evolution of Siglec-1 nanoclusters and LUV spatial dispersion within the plasma membrane of mDCs along time (representative images shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). In the case of high GM-1 concentrations (4%), with more ligand available to interact with Siglec-1 receptors, 30 min of binding led on average to ~1.5-fold increase in the number of colocalizing Siglec-1 molecules per spot with respect to the values measured immediately after binding (5 min) (<xref ref-type="fig" rid="fig5">Figure 5G</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). In contrast, in the case of LUVs with low (0.5%) GM-1, the number of colocalizing Siglec-1 molecules/spot did not increase to the same level as to the high GM-1 concentration until 60 min (<xref ref-type="fig" rid="fig5">Figure 5G</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). Interestingly, LUVs with high GM-1 concentration exhibited a clear polarization toward the cell center at 30 min of capture (<xref ref-type="fig" rid="fig5">Figure 5H</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>), whereas the low GM-1 LUVs did not show such polarization until 60 min (when the number Siglec-1 molecules per spot colocalizing with LUVs also starts to increase) (<xref ref-type="fig" rid="fig5">Figure 5I</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). Altogether these results suggest that active Siglec-1 clustering, which is mediated by the sole interaction of Siglec-1 with its ligand GM-1, regulates the trafficking of Siglec-1 receptors toward the later formation of the VCC.</p><p>Notably, Siglec-1 receptors not colocalizing with either VLPs or high GM-1 concentration LUVs also showed some degree of polarization toward the cell center after 30 min of incubation, which was reflected by a significant increase in the proximity between non-colocalizing and colocalizing spots along time (<xref ref-type="fig" rid="fig5">Figure 5J, K</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). In contrast, such effect was only observed at later times (60 min) when cells were pulsed with low GM-1 concentration LUVs (<xref ref-type="fig" rid="fig5">Figure 5K</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>), indicating that at these low concentrations, polarization progressed slower. Finally, we also observed a slight but significant increase in the clustering of non-colocalizing Siglec-1 spots for the cases of VLPs and of high GM-1 concentration LUVs at early capture times, which was only detected at 60 min for low GM-1 LUVs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref> and <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>). Altogether these results suggest that Siglec-1 enhanced nanoclustering induced by multiple ligand/receptor interactions causes a global nano- and meso-scale rearrangement of the receptor which would then facilitate its trafficking to the VCC.</p></sec><sec id="s2-6"><title>Binding of Siglec-1 to HIV-1 particles induces a global reorganization of the actin cytoskeleton facilitating the formation of a single VCC in mDCs</title><p>We have shown that Siglec-1 lateral mobility and nanoscale organization at steady state is controlled by the underlying actin cytoskeleton, dependent on formins and Rho activity. To address how the actin cytoskeleton might also regulate the changes in the nano- and meso-scale organization of Siglec-1 upon binding to gangliosides carrying sialic acid ligands, we performed 3D-confocal imaging on fixed and stained mDCs for actin and Siglec-1 after different times of incubation with either VLPs or LUVs carrying high and low GM-1 concentrations (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). After 30 min of incubation, colocalization of Siglec-1 and VLPs or high GM-1 (4%) LUVs occurred in a ring-shaped compartment within the first 4 µm above the basal membrane (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B</xref> and <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>). Moreover, this was accompanied by a clear polarization of the actin cytoskeleton, characterized by a significant reduction of the cell area at the planes where the ring was formed (<xref ref-type="fig" rid="fig6">Figure 6B</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref> for VLP, and <xref ref-type="fig" rid="fig6">Figure 6C–E</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref> for LUVs) and by the onset of numerous membrane ruffles in the apical parts of the cell (bottom panels in <xref ref-type="fig" rid="fig6">Figure 6A</xref>). By contrast, pulsing the cells with low GM-1 (0.5%) concentration LUVs, resulted in a significant delay both, in the accumulation of Siglec-1 and LUVs in a narrow ring-shaped compartment (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), as well as in the constriction of the basal membrane (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Together, these results show a direct correlation between the ability of VLPs or LUVs (with high GM-1 content) to promote enhanced Siglec-1 nanoclustering and the induction of downstream global actin rearrangements.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Binding of Siglec-1 to HIV-1 induces a global reorganization of the actin cytoskeleton which allows the final formation of a single virus-containing compartment (VCC) in mature dendritic cells (mDCs).</title><p>(<bold>A</bold>) Confocal maximum intensity projections of 3D confocal images on fixed mDCs immunostained with anti-Siglec-1, SiR-actin and incubated for different times with VLP-Gag-Cherry or tRedLUVs. A ring-shape region or compartment is clearly observed at 30 min of incubation with VLPs or 4% GM1 LUVs, with increased colocalization of Siglec-1, VLPs (or GM1), and actin occurring at axial distances of 4–6 μm above the basal membrane plane (see <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B</xref> and <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1for</xref> quantification). Color-coded outlines below each image show the cell perimeter in the axial plane obtained from 3D confocal stacks images (10–15 stacks of 1.5 µm per cell). (<bold>B</bold>) Cell area in the axial plane in mDC for different incubation times with VLPs. Data correspond to the mean ± standard error of the mean (SEM) of 4 (time points 5 and 30 min) and 3 donors (60 min), 7 cells/donor and condition. (<bold>C–E</bold>) Plots as in B for mDC pulsed with LUVs carrying 0.5% and 4% GM-1 for different incubation times (C, 5 min; D, 30 min; E, 60 min). Mean ± standard deviation (SD) of minimum of 7 cells per time and condition. (<bold>F</bold>) Confocal projections of mDC stained with anti-pERM in control conditions (left) or pre-treated for 4 hr with CN03 (right), in the absence (top panels) or the presence of VLP-Gag-Cherry for 60 min (bottom panels). Below scale-colored projections of the cell edges from the bottom to the top of control and CN03-treated mDC after 60 min of VLP capture. (<bold>G</bold>) Average pERM intensity in mDC before and after 60 min of VLP capture (3 donors, at least 7 cells/donor). Red dots are the mean values of each donor. (<bold>H</bold>) Average pERM intensity in control mDC and cells pre-treated with the Rho activator CN03 before and after 60 min of VLP capture. Mean ± SD of a minimum of 7 cells per condition. (<bold>I</bold>) Cumulative frequency plots of VLP intensity as a function of the distance from their center of mass in control mDC and cells pre-treated with CN03 after 60 min of VLP capture. Mean + SD of a minimum of 7 cells per condition. (<bold>J</bold>) Cell area in the axial plane in control and CN03-treated mDC after 60 min of incubation with VLPs. Mean ± SD of a minimum of 7 cells per condition. Statistics in the legends of panels B–E, J correspond to the significance of a two-way analysis of variance (ANOVA) test depending on time after VLP addition (<bold>A</bold>) percentage of GM-1 (<bold>C–E</bold>) or treatment (control mDC vs. CN03-treated cells). Statistics in the legends of panel I correspond to the significance of a Mann–Whitney comparing the distance from the center-of-mass of VLP at which we recover 50% of the total intensity of VLP-Gag-Cherry. ns, p &gt; R 0.05, * p &lt; % 0.05, ** p &lt; % 0.001; *** p &lt; % 0.0001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Excel file containing the source data for <xref ref-type="fig" rid="fig6">Figure 6B–E, G–J</xref>, and <xref ref-type="fig" rid="fig6">Figure 6G–J</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Binding of Siglec-1 to HIV-1 induces a global reorganization of the acti cytoskeleton which allows the final formation of a single VCC in mDCs.</title><p>(<bold>A</bold>) Manders coefficients in the axial plane of Siglec-1 colocalizing with VLP-Gag-Cherry (representative 3D confocal images in <xref ref-type="fig" rid="fig6">Figure 6A</xref>). Data in (<bold>A</bold>) show the mean + standard error of the mean (SEM) of 3 (time points of 5 and 30 min) and 2 donors (60 min) with a minimum of 9 cells/donor and time. (<bold>B</bold>) Same as in A but in cells incubated with 4.0% GM-1 LUVs. Data correspond to the mean + standard deviation (SD) of a minimum of 7 cells per time and condition. (<bold>C</bold>) Representative confocal images of mature dendritic cell (mDC) immunostained with anti-pMLC and SiR-actin at steady state and after 60 min of incubation with VLP-Gag-Cherry. Images in the bottom show projections of color-coded intensity values for pMLC. (<bold>D</bold>) pMLC intensity in mDC at steady state and after 60 min incubation with VLP-Gag-Cherry. Data correspond to the mean + SD from one representative experiment (<italic>N</italic> = 2) counting 7 cells per condition. (<bold>E</bold>) Representative immunoblots from cell extracts of mDC at steady state and incubated in the presence of VLP-Gag-Cherry for different times. Equal amounts of protein loaded in each line were revealed with anti-cofilin, p-cofilin (S19), and b-actin. Bars in the bottom graph show the mean + SEM. of three independent experiments quantifying the ratio between p-cofilin and cofilin levels normalized to time 0 min. * p &lt; % 0.05, ** p &lt; % 0.001.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Excel file containing the source data for panels A, B, D, E.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Zip folder containing the original files of the full raw unedited blots corresponding to <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78836-fig6-figsupp1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig6-figsupp1-v2.tif"/></fig></fig-group><p>We described that Siglec-1 steady-state distribution was mainly found in regions of the plasma membrane regulated by Rho activity and enriched in pERM. Interestingly, when mDCs were pulsed with VLPs we observed a general reduction of pERM as compared to control (i.e., in the absence of VLP) (<xref ref-type="fig" rid="fig6">Figure 6F, G</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). This drop in pERM suggests a drop in Rho activity and indeed, we observed a similar decay in the levels of the ROCK downstream effectors pMLC (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C, D</xref> and <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>) and p-cofilin (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>, <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig6s1sdata2">Figure 6—figure supplement 1—source data 2</xref>) after 60 min of VLP capture. Thus, Rho inactivation might be responsible for the major actin reorganization observed and the polarization of VLPs toward the final formation of the VCC.</p><p>To test this hypothesis, we pre-treated mDCs with the Rho activator CN03. Activation of Rho led to a homogeneous increase in the levels of pERM as compared to control cells, and such difference remained after 60 min of incubation with VLPs (<xref ref-type="fig" rid="fig6">Figure 6F, H</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Importantly, pre-treatment with CN03 delayed the polarization of VLPs into a ring-shape compartment (<xref ref-type="fig" rid="fig6">Figure 6I</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>) and delayed the constriction of the membrane within the planes of VLP accumulation (<xref ref-type="fig" rid="fig6">Figure 6J</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Altogether these results strongly indicate that actin remodeling associated to Siglec-1 clustering caused by multiple ligand interactions and the subsequent effect on Rho inactivation is essential for the formation at later stages of the VCC in mDCs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Several studies have reported the importance of the actin cytoskeleton in almost all the steps of HIV-1 infection (<xref ref-type="bibr" rid="bib3">Audoly et al., 2005</xref>; <xref ref-type="bibr" rid="bib24">Felts et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Gladnikoff et al., 2009</xref>; <xref ref-type="bibr" rid="bib34">Harmon et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Iyengar et al., 1998</xref>; <xref ref-type="bibr" rid="bib38">Izquierdo-Useros et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Jolly et al., 2007</xref>; <xref ref-type="bibr" rid="bib45">Kerviel et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Ménager and Littman, 2016</xref>; <xref ref-type="bibr" rid="bib61">Nikolic et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Sasaki et al., 1995</xref>; <xref ref-type="bibr" rid="bib78">Shrivastava et al., 2015</xref>; <xref ref-type="bibr" rid="bib92">Wang et al., 2007</xref>). In this study, we demonstrated that RhoA activity and formin-dependent actin polymerization regulate Siglec-1 organization on the membrane of mDCs by forming receptor nanoclusters that increase the avidity for HIV-1 capture (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Our results indicate that differences in actin polymerization mechanisms between iDCs and mDCs are responsible for clustering of Siglec-1 upon DC activation. Along these lines, recent studies have shown that Arp2/3-dependent branched actin is predominant in iDCs, whereas formation of actin bundles by formins is the main mechanism in mDCs (<xref ref-type="bibr" rid="bib89">Vargas et al., 2016</xref>). Accordingly, our results show that in mDCs, Siglec-1 exhibits an uneven distribution, with high-density regions in polarized areas of the plasma membrane that are enriched in the Rho downstream effector pERM, and can be disrupted by the inhibition of RhoA, ROCK, and formins. Interestingly, the abrogation of basal nanoclustering decreases the binding of HIV-1 particles to Siglec-1. Moreover, liposomes with low concentrations of the Siglec-1 ligand GM1 can only bind to large Siglec-1 clusters. These results indicate that the polarized distribution and nanoclustering of Siglec-1 in high-density regions of the membrane may provide very efficient docking platforms capable to interact with HIV-1 and other enveloped viruses even with limited concentrations of gangliosides on their membrane (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). It is tempting to speculate that mDCs subjected to chemokine gradients in 3D environments, which enhance the polarization of Rho and formin actin polymerization at the trailing edge of migrating cells (<xref ref-type="bibr" rid="bib49">Lämmermann et al., 2009a</xref>; <xref ref-type="bibr" rid="bib50">Lämmermann and Sixt, 2009b</xref>; <xref ref-type="bibr" rid="bib62">Nitschké et al., 2012</xref>; <xref ref-type="bibr" rid="bib90">Vargas et al., 2017</xref>), could increase HIV-1 capture by enhancing the confinement of Siglec-1 receptors at the back of the cell (the uropod). During the natural course of HIV-1 infection there is an increase in the levels of LPS in the serum, mainly due to bacterial translocation induced by damage in the gut epithelium (<xref ref-type="bibr" rid="bib10">Brenchley et al., 2006</xref>). It would be interesting to address if the expected changes in the nanoscale organization of activated DCs during migration from peripheral tissues are maintained once DCs reach the lymph nodes, increasing the efficiency of viral capture and <italic>trans-</italic>infection.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Model of HIV-1 capture by Siglec-1 and polarization toward the formation of the virus-containing compartment (VCC) in mature dendritic cell (mDC).</title><p>(<bold>A</bold>) In steady state, Siglec-1 receptors in mDCs are organized in small nanoclusters proximal to each other. This basal nanoclustering occurs by spatiotemporal confinement of Siglec-1 diffusion into plasma membrane regions dependent on Rho activity, its downstream effector ROCK, pERM, and formin-mediated actin polymerization (see in the middle panel a representation of the cross-section in the 3D reconstruction of a whole cell at early stages of HIV-1 capture). We propose that Siglec-1 mobility is restricted by transmembrane proteins that interact with the filamentous cortical actin cytoskeleton through activated ERM proteins in polarized regions of the mDC membrane (right). Siglec-1 basal nanoclustering is especially relevant to increase the avidity of Siglec-1 for the gangliosides in the membrane of the HIV-1, and therefore regulates the capture capacity of HIV-1 by mDC. (<bold>B</bold>) At late stages of HIV-1 capture, Siglec-1 clustering increases and most receptors accumulate in a polarized ring-shaped compartment that progressively constrains the membrane (see in the middle panel a representation of the cross-section in the 3D reconstruction of a whole cell at late stages of HIV-1 capture). These changes are accompanied by massive actin rearrangements that include extensive membrane ruffling above the plane in which Siglec-1 and HIV-1 accumulate and by a contraction of the membrane below the ring. This polarization requires a temporal drop in Rho activity. We propose that Rho inactivation would allow for the free diffusion of Siglec-1 through the membrane until being trapped by direct interaction with HIV-1 in the highly dense Siglec-1 regions in which initially most viruses are bound. In parallel, a drop in Rho activity would also lead to actin depolymerization and a decrease in membrane tension together with a retraction of the basal membrane. Both factors would favor the proximity between Siglec-1 bound to HIV-1 clusters and the progressive bending of the membrane until the formation of a single VCC.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78836-fig7-v2.tif"/></fig><p>Previous reports have shown that the organization in membrane microdomains of receptors involved in viral binding, like DCSIGN, enhances the avidity of those receptors for their ligands (<xref ref-type="bibr" rid="bib12">Cambi et al., 2004</xref>). However, this effect is largely dependent on the size of the cargo. Siglec-1 is involved in the capture of other cargoes carrying sialylated gangliosides aside from HIV-1 (<xref ref-type="bibr" rid="bib65">Perez-Zsolt et al., 2019</xref>; <xref ref-type="bibr" rid="bib73">Saunderson et al., 2014</xref>). Some of them have sizes considerably larger than HIV-1, like the Ebola virus (&gt;1 µm length), whereas others, like exosomes, exosome-like vesicles, ectosomes, or apoptotic vesicles can have a broad range of sizes below 100 nm (<xref ref-type="bibr" rid="bib82">Théry et al., 2009</xref>). Thus, Siglec-1 nanoclustering may have a different impact in the capture of particulate antigens depending on their structural properties. This possibility can extend the relevance of Siglec-1 spatial organization to other immunological processes like antigen presentation of MHC-I and MHC-II/antigen complexes captured from secreted exosomes (<xref ref-type="bibr" rid="bib2">André et al., 2004</xref>; <xref ref-type="bibr" rid="bib6">Benet et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Chaput et al., 2004</xref>; <xref ref-type="bibr" rid="bib76">Segura et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Théry et al., 2002</xref>; <xref ref-type="bibr" rid="bib91">Wakim and Bevan, 2011</xref>).</p><p>Our study also underscores the mechanism by which formin-dependent actin polymerization and Rho-ROCK signaling regulates the nanoscale organization of Siglec-1. Our observations on the diffusion behavior of Siglec-1 in mDCs, with a high fraction of molecules displaying immobile or confined motions, suggest that Siglec-1 nanoclustering results from its spatiotemporal confinement in the membrane, which could facilitate the lateral interaction with proximal Siglec-1 receptors. However, Siglec-1 receptors do not possess known cytosolic motifs that directly or indirectly interact with the actin cytoskeleton (<xref ref-type="bibr" rid="bib7">Bornhöfft et al., 2018</xref>). Nevertheless, it is known that the lateral diffusion of lipids and receptors in the plasma membrane can be constrained by interactions with immobile transmembrane proteins or ‘pickets’, directly connected to the cortical actin through linker proteins like ezrin (<xref ref-type="bibr" rid="bib26">Freeman et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Kalay et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Kusumi et al., 2012</xref>; <xref ref-type="bibr" rid="bib85">Trimble and Grinstein, 2015</xref>). The fact that pharmacological inhibition of ROCK and its downstream effector ERM can partially disrupt Siglec-1 nanoclustering and its polarization in highly dense areas of the plasma membrane supports the existence of such protein pickets acting on Siglec-1 (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Proteins like CD44 can exert this picket function and confine the diffusion of other transmembrane receptors at zones enriched in pERM and formin-dependent actin polymerization at the trailing edge of mDCs (<xref ref-type="bibr" rid="bib26">Freeman et al., 2018</xref>; <xref ref-type="bibr" rid="bib79">Sil et al., 2019</xref>). It remains to be investigated whether amongst the cofactors needed for the formation of the VCC (<xref ref-type="bibr" rid="bib1">Akiyama et al., 2015</xref>), there are also proteins acting as diffusion barriers to confine Siglec-1 in restricted areas of the cell.</p><p>Lastly, we showed that active Siglec-1 clustering promoted by interactions with HIV-1 is essential to regulate its trafficking toward the final formation of the VCC. Importantly, the proximity between VLPs proceeds in parallel with a progressive clustering of Siglec-1, which is much more pronounced in the case of mDCs as compared to iDCs, and dynamically dependent on the concentration of gangliosides in the viral membrane. Indeed, when mDCs are pulsed with liposomes carrying low concentrations of GM-1 we observed a significant delay in the growth of Siglec-1 clusters and a more disperse distribution of these liposomes within the cell membrane, as compared to those with high GM-1 concentrations. In addition, the polarization of viral particles in a ring-shape compartment triggered several morphological changes in mDCs: emergence of membrane ruffles, shrinkage of the basal membrane, and constriction of the cell membrane at the plane where VLPs accumulate. These results indicate that active clustering of Siglec-1 is capable of triggering a downstream signaling cascade that dramatically affects the actin cytoskeleton of mDCs. Accordingly, we showed that VLPs accumulation into the ring-shape compartment coincides with a decay in the levels of the ROCK effectors pERM, pMLC, and p-cofilin. Moreover, pharmacological activation of Rho caused a delay in the constriction of the ring-shape compartment, indicating that Rho inhibition is required for the proper polarization of VLPs toward the final formation of the VCC. A decay in Rho activity may, on the one hand, decrease actin polymerization by formins and activate severing of filamentous actin by cofilin (<xref ref-type="bibr" rid="bib80">Sit and Manser, 2011</xref>), which could explain the retraction of the basal membrane. On the other hand, the inhibition of pERM, one of the main regulators of membrane tension (<xref ref-type="bibr" rid="bib54">Liu et al., 2012a</xref>; <xref ref-type="bibr" rid="bib71">Rouven Brückner et al., 2015</xref>) might facilitate the observed constriction of the membrane at the plane where the virus accumulate. Both phenomena would enhance the proximity between Siglec-1/HIV-1 complexes facilitating the lateral fusion of molecules until a VCC is formed (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Interestingly, it has been shown that monocyte-derived macrophages (MDMs) express Siglec-1 on the cell surface and that these cells are able not only to capture VLPs but also to rapidly internalize particles into the VCC in a Siglec-1 and ganglioside-dependent manner (<xref ref-type="bibr" rid="bib33">Hammonds et al., 2017</xref>). It is thus tempting to speculate that similar to mDCs as shown here, macrophages could also use an actin-dependent mechanism to increase the avidity of Siglec-1 to VLPs via nanoclustering of the receptor and for orchestrating the earliest events that finally lead to VCC formation.</p><p>How Siglec-1 clustering is capable to activate such changes needs further investigation. The fact that the cytosolic domain of Siglec-1 is not essential for the formation of the VCC reinforces the idea that other cofactors might co-cluster with Siglec-1 to activate intracellular signaling cascades. Interestingly, the cross-linking of several tetraspanins, which are highly enriched in the VCC (<xref ref-type="bibr" rid="bib27">Garcia et al., 2005</xref>; <xref ref-type="bibr" rid="bib39">Izquierdo-Useros et al., 2012a</xref>; <xref ref-type="bibr" rid="bib69">Puryear et al., 2013</xref>), can induce actin rearrangements through the modulation of Rho GTPases (<xref ref-type="bibr" rid="bib9">Brazzoli et al., 2008</xref>; <xref ref-type="bibr" rid="bib19">Delaguillaumie et al., 2002</xref>; <xref ref-type="bibr" rid="bib43">Jones et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Liu et al., 2012b</xref>). Furthermore, the spatial organization of tetraspanins in the so-called tetraspanin-enriched microdomains (TEMs) is also regulated by interactions with certain lipids like cholesterol (<xref ref-type="bibr" rid="bib94">Zimmerman et al., 2016</xref>) and gangliosides (<xref ref-type="bibr" rid="bib63">Odintsova et al., 2006</xref>). Yet, it is not known if some trans-interactions between the tetraspanin web and the gangliosides exposed in the membrane of HIV-1 can also affect the coalescence of multiple TEM (<xref ref-type="bibr" rid="bib20">Delaguillaumie et al., 2004</xref>). The formation of the VCC could be the result of a synergistic cooperation between the capacity of several tetraspanins to modulate positive and negative membrane curvature (<xref ref-type="bibr" rid="bib20">Delaguillaumie et al., 2004</xref>; <xref ref-type="bibr" rid="bib22">Dharan et al., 2023</xref>; <xref ref-type="bibr" rid="bib21">Dharan et al., 2022</xref>; <xref ref-type="bibr" rid="bib63">Odintsova et al., 2006</xref>) and the differential lipid composition of TEMs, which could facilitate domain-induced inward budding to minimize the line energy at the TEM-membrane interface (<xref ref-type="bibr" rid="bib5">Baumgart et al., 2003</xref>; <xref ref-type="bibr" rid="bib52">Lipowsky, 1992</xref>; <xref ref-type="bibr" rid="bib53">Liu et al., 2006</xref>). In this regard, the use of single-particle tracking and super-resolution microscopy can be of great interest to further investigate the molecular composition of Siglec-1/HIV-1 clusters within the course of the VCC formation, as well as to identify new key regulators of this process.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Antibodies and reagents</title><p>Mouse monoclonal antibodies to Siglec-1 (Hsn 7D2) and rabbit polyclonal antibodies against cofilin and phospho-cofilin (phospho S3) were obtained from Abcam. Rabbit antibodies against pERM (48G2) and pMLC were purchased from Cell Signaling. Anti-Mouse IgG F(ab) ATTO488 was from Hypermol and Anti-Rabbit IgGF(ab) Cy3 was from Jackson Immunoresearch. Donkey anti-mouse AlexaFluor Plus 488 secondary antibody was from Thermo Fisher. The SIR-Actin Spirochrome Kit (CY-SC001), the Rho Inhibitor I ADP ribosylation of Rho Asn-41 (CT04) and Rho Activator II (CN03) were obtained from Cytoskeleton. The phosphor-ezrin inhibitor NSC668394 was from Calbiochem. The pan-formin inhibitor SMIFH2, the Arp2/3 inhibitor CK-666 and the actin polymerization inhibitor CytoD were purchased from SIGMA. The ROCK inhibitor Y-27632 was obtained from Merk Millipore.</p></sec><sec id="s4-2"><title>Primary cell cultures</title><p>Peripheral blood mononuclear cells (PBMCs) were obtained with a Ficoll-Hypaque gradient (Alere Technologies AS) from HIV-1-seronegative donors, and monocyte populations (&gt;97% CD14<sup>+</sup>) were isolated with CD14-positive selection magnetic beads (Miltenyi Biotec). DCs were obtained by culturing these cells in the presence of 1000 IU/ml granulocyte-macrophage colony-stimulating factor and interleukin-4 (both from R&amp;D) for 7 days and replacing media and cytokines every 2 days. Activated DCs were differentiated by culturing iDCs at day 5 for 2 more days in the presence of 100 ng/ml LPS (Sigma-Aldrich) to induce Siglec-1 expression.</p></sec><sec id="s4-3"><title>Plasmids and viral like particle (VLP) stock production</title><p>HIV-1-Gag-mCherry-env HXB2 were obtained by co-transfection 1:1 (wt/wt) of the molecular clones pcDNA HIV Gag Cherry (kindly provided by Dr. Gummuluru; 15 µg) and pcDNA HIV-1 env HXB2 (15 µg). HEK-293T cells were transfected with calcium phosphate (Clontech) in T75 flasks using a total of 30 μg plasmid DNA. Seventy-two hours post-transfection, supernatants containing virus were cleared of cellular debris by centrifugation, filtered (0.45 μm; Millipore) and frozen at −80°C until use.</p></sec><sec id="s4-4"><title>Generation of LUVs</title><p>LUVs were prepared following the extrusion method described in <xref ref-type="bibr" rid="bib58">Mayer et al., 1986</xref>. Lipids were purchased from Avanti Polar Lipids and gangliosides were obtained from Carbosynth. The LUV-tRed lipid composition was: POPC 25 mol%: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 16 mol%: brain sphingomyelin (SM), 14 mol%: cholesterol (Chol), 39 mol %: GM-1 from 4 to 0.25 mol%. 4% of gangliosides content corresponds to approximately 12,000 gangliosides, mimicking the lipid composition of HIV-1 or VLPs (<xref ref-type="bibr" rid="bib11">Brügger et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Chan et al., 2008</xref>). Reducing the ganglioside content allowed us to test the role for Siglec-1 nanoclustering in increasing the avidity of receptors to gangliosides carrying sialic acid ligands. All the LUVs contained 2 mol% of 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE)-tRed (Molecular Probes). Lipids were mixed in chloroform:methanol (2:1) and dried under nitrogen. Traces of organic solvent were removed by vacuum pumping for 1–2 hr. Subsequently, the dried lipid film was dispersed in N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)- sodium buffer and subjected to ten freeze-thaw cycles prior to extruding ten times through two stacked polycarbonate membranes with a 100-nm pore size (Nucleopore, Inc) using the Thermo-barrel extruder (Lipex extruder, Northern Lipids, Inc). To perform mDC pulse with equal concentrations of LUV displaying similar fluorescence intensities, tRed containing LUVs concentration was quantified following the phosphate determination method (<xref ref-type="bibr" rid="bib8">Böttcher et al., 1961</xref>) and the fluorescence emission spectra were recorded setting the excitation at 580 nm in a SLM Aminco series 2 spectrofluorimeter (Spectronic Instruments).</p></sec><sec id="s4-5"><title>Immunoblot</title><p>DCs derived from PBMCs treated with LPS for 48 hr were seeded at a concentration of 0.5 × 10<sup>6</sup> cells well in 12-well plates coated with poly-L-lysine (30 µg/ml). After 1 hr of adhesion cells were pulsed with 50 µl of VLP-Gag-Cherry particles in each well, and gently scrapped on ice after different times of incubation at 37°C. Cell pellets were lysed in Triton X-100 lysis buffer (Thermo Fisher) supplemented with protease inhibitors (Roche), and 10 µg of protein samples were prepared adding NuPAGE LDS Sample Buffer (Thermo Fisher) with 2.5% beta-mercaptoethanol (Sigma). Samples were further denatured at 80°C for 5 min and loaded in 12% acrylamide gels (Bio-Rad). Electrophoresis was carried in Tris-Acetate SDS running buffer (Bio-Rad) at 100 V and transfer to nitrocellulose membranes was done in Towbin buffer (25 mM Tris, 192 mM glycine, 20% (vol/vol) methanol) for 90 min at 100 V. Membranes were incubated with primary and HRP-secondary antibodies in 1X Tris-Buffered Saline, 0.1% Tween 20 Detergent (TBST)buffer with 5% milk (room temperature for 1 hr or overnight at 4°C) and revealed with an ECL solution (BIO-Rad) following the manufacturer’s instructions.</p></sec><sec id="s4-6"><title>Generation of single-chain antibodies</title><p>Monovalent mouse monoclonal [HSn 7D2] anti-human Siglec-1 Abs were prepared by reduction of the full antibody with Dichlorodiphenyltrichloroethane (DTT) at 10 mM for 30 min at room temperature. DTT was removed dialyzing the samples in phosphate-buffered saline (PBS) using Zeba Spin Desalting Columns (Thermo Scientific) and when required monovalent antibodies were further concentrated using Centricon concentrators according to the manufacturer’s instructions. To verify the generation of single-chain antibodies we prepared samples of whole and reduced antibodies with NuPAGE LDS Sample Buffer (4×) and run them in NuPAGE 7% Tris-Acetate Protein Gels (Bio-Rad) in denaturing, non-reducing conditions. Electrophoresis was performed in Tris-Acetate SDS running buffer (Bio-Rad) at 100 V and gels were stained with Coomassie for 1 hr at room temperature (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref> and <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>).</p></sec><sec id="s4-7"><title>Sample preparation for STED and confocal imaging in fixed cells</title><p>1.5 × 10<sup>5</sup> immature and LPS (100 ng/ml for 48 hr) matured DCs were plated on glass slides coated with poly-lysine (10 µg/ml). After DCs adhesion to culture plates, cells were pulsed with either VLP-Gag-Cherry particles (30 µl of concentrated VLPs per 1.5 × 10<sup>5</sup> cells plated in 270 µl RPMI, final VLP concentration ~2.5 ng per 10<sup>5</sup> cells) or LUVs carrying different concentration of GM-1 (200 µM) for 5 min to 1 hr at 37°C. After extensive washing, cells were fixed in 4% PFA (10 min at room temperature) and rinsed with NH<sub>4</sub>Cl (50 mM in PBS). When needed, permeabilization was done with saponin 0.01% in PBS (10 min, RT). Immunostaining of Siglec-1was done incubating primary and secondary antibodies (1 hr, room temperature) in PBS 1% bovine serum albumin. Specifically, full antibody (mouse monoclonal anti-Siglec-1 [Hsn 7D2] obtained from Abcam) as well as single-chain antibody were used at a final concentration of 10 µg/ml. Secondary antibody (donkey anti-mouse AlexaFluor Plus 488) was used at a final concentration of 20 µg/ml. SiR-actin was added at 1 µM together with primary antibodies. After several washes in PBS glass slides were covered with Fluoromount aquose mounting media (Sigma). When indicated cells were incubated with CytoD (2 µg/ml), CK666 (100 µM), SMIFH2 (25 µM), and Y-27623 (30 µM) for 1 hr at 37°C in complete RPMI (10% fetal bovine serum [FBS], <sc>L</sc>-glutamine) prior fixation. NSC668394 (250 µM) was added for 3 hr at 37°C in complete RPMI. CT04 (2 µg/ml) and CN03 (2 µg/mL) were added for 3–4 hr at 37°C in RPMI without FBS. When cells were incubated with VLP-Gag-Cherry the concentration of the drugs was maintained for all the time until fixation.</p><p>Control experiments were performed using single-chain Abs to label Siglec-1 (instead of full Abs) to exclude any potential artifacts associated with our labeling strategy. As additional controls, we also tried different fixation protocols in combination with single-chain Ab labeling, specifically: 4% PFA (10 min at room temperature) and 1% PFA + 0.2% glutaraldehyde (GA) (10 min at room temperature). Samples from three different donors were prepared as described above.</p></sec><sec id="s4-8"><title>STED imaging</title><p>STED super-resolution images of DCs were acquired with a confocal microscope (Leica TCS SP8, Leica Microsystems) equipped with an oil immersion objective (HCX PL APO CS x100, Leica) with a 1.4 numerical aperture. Samples were excited with a white light laser (WLL) at 488 nm (Alexa488), 587 nm (mCherry), 583 nm (tRed), and 633 nm (SiR) fixing the laser power to optimal conditions (5–20%) for each experiment. Emission spectra were in the range of 500–540 nm (Alexa488), 550–650 nm (mCherry and tRed), and 645–661 nm (SiR). STED laser beams intensities at 592 nm (Alexa488) and 775 nm (mCherry, tRed, and SiR) were set to 50% and 100% of their power, respectively. Images were acquired with a format of 1024 × 1024 pixels at 400 Hz with a pixel size of ~14–30 nm, adjusting frame accumulation (1–5) and line average (1–5) to a non-saturating signal for each staining, keeping the same conditions for all the cells analyzed in one experiment.</p></sec><sec id="s4-9"><title>Quantification of number of molecules per spot</title><p>To define the area of Siglec-1 individual spots STED images were processed using Fiji to apply a subtraction of the background and a Gaussian blur filter (sigma radius 1) followed by a difference of Gaussian (smaller/greater sigma 1:3). Then an intensity threshold was used to create binary masks of the individual spots from which we obtain the mean intensity values per each spot within the original images. Thereafter, we used a MATLAB code (<xref ref-type="bibr" rid="bib56">Manzo, 2017</xref>, <ext-link ext-link-type="uri" xlink:href="https://github.com/cmanzo/DECO">https://github.com/cmanzo/DECO</ext-link>) to fit the distribution of intensities of individual spots from antibodies on glass to a lognormal function (<italic>f</italic><sub>1</sub>).<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mtext> </mml:mtext><mml:mtext> </mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>I</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mi>π</mml:mi></mml:msqrt><mml:mi>σ</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mtext> </mml:mtext><mml:mi>l</mml:mi><mml:mo>−</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:math></disp-formula></p><p>This model corresponds to the expected theoretical distribution for the intensity corresponding to the detection of a fluorescent emitter (<xref ref-type="bibr" rid="bib93">Zanacchi et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Ménager and Littman, 2016</xref>; <xref ref-type="bibr" rid="bib75">Schmidt et al., 1996</xref>). The intensity values obtained from spots on glass were used to define the <italic>µ</italic> (mean) and <italic>σ</italic> (standard deviation) of the lognormal distribution, through its fit to a linear combination of <italic>N</italic> = 2 functions. These parameters were used as a single-molecule reference to define the stoichiometry of the fluorescence of Siglec-1 receptors in the cells measured under identical experimental conditions (<xref ref-type="bibr" rid="bib84">Torreno-Pina et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">van Zanten et al., 2009</xref>). As expected, the intensity histograms of Siglec-1 spots on samples showed higher intensities and broader distributions than the antibodies on glass, indicative of a mixture of different populations of nanoclusters composed by a different number of molecules. To calculate the probability distribution of molecules per spot, the intensity histograms of Siglec-1 spots on cells were fitted to a model distribution <italic>g</italic><sub><italic>N</italic></sub>(<italic>I</italic>) composed of a linear combination of functions as described in <xref ref-type="bibr" rid="bib57">Martínez-Muñoz et al., 2018</xref>.<disp-formula id="equ2"><mml:math id="m2"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>∙</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math></disp-formula></p><p>where <italic>f<sub>n</sub></italic> shows the intensity distribution intensity of a spot containing n receptors, and <italic>α<sub>n</sub></italic> is the relative weight of this distribution so that <inline-formula><mml:math id="inf1"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></inline-formula> , being <italic>N</italic> the maximum number of receptors (in our analysis 12) (<xref ref-type="bibr" rid="bib59">Ménager and Littman, 2016</xref>). We considered that the distribution for a spot containing <italic>n</italic> receptors could be obtained recursively as<disp-formula id="equ3"><mml:math id="m3"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mo>⨂</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></disp-formula></p><p>where ⊗ represents the convolution of the intensity distribution lognormal functions for <italic>n</italic> = 1, 2, …, 12 (<xref ref-type="bibr" rid="bib59">Ménager and Littman, 2016</xref>; <xref ref-type="bibr" rid="bib75">Schmidt et al., 1996</xref>; <xref ref-type="bibr" rid="bib84">Torreno-Pina et al., 2016</xref>).</p></sec><sec id="s4-10"><title>Determination of number of molecules per spot colocalizing with VLPs</title><p>To classify Siglec-1 clusters according to their colocalization with VLPs, STED images from each channel were processed as described in quantification of molecules per spot followed by an intensity threshold segmentation of individual spots to create binary masks. The binary images of segmented spots in each channel were overlapped to identify Siglec-1 colocalizing clusters (with an average area overlap for each siglec-1 spot of ~60% ± 27%). Then, we obtained the Siglec-1 mean intensity values of the spots colocalizing with VLPs from the original unprocessed images, which we used to calculate the probability distribution of number of molecules per spot in the Siglec-1/VLP colocalizing fraction as described above (see quantification of the number of molecules per spot).</p><p>To quantify the local density of Siglec-1 molecules surrounding the colocalizing spots, we selected all the spots whose centroids were enclosed in different radius from the centroid of each colocalizing spot. We then used their mean intensity values to assign a number of molecules (<italic>n</italic>) to each spot (see quantification of molecules per spot). The density (<italic>d</italic>) of molecules within a radius <italic>r</italic> was,<disp-formula id="equ4"><mml:math id="m4"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:mfenced><mml:mi> </mml:mi><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mfrac><mml:mrow><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mo>∙</mml:mo><mml:mi> </mml:mi><mml:mi>n</mml:mi><mml:mi> </mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <italic>Z<sub>n</sub></italic> is the total number of spots with <italic>n</italic> molecules and <italic>N</italic> the maximum number of molecules per spot.</p><p>To quantify the dispersion of VLPs and LUVs colocalizing with Siglec-1 we measured the distance of each individual particles from its center to the center-of-mass of all the Siglec-1 spots. This distance versus the accumulated intensity frequency was fit to a sigmoidal equation from which we obtained the distance covering 50% of the Siglec-1 intensity for each cell, which was used as reference parameter for statistical analysis. To quantify the proximity between Siglec-1 spots colocalizing or not with VLP/LUV, individual Siglec-1 spots were segmented for colocalization as described above and we measured the average distance between the centers of all non-colocalizing spots to the center of each individual colocalizing spot.</p></sec><sec id="s4-11"><title>Generation of in silico random images</title><p>To generate in silico images with a random distribution we calculated the FWHM of individual spots by averaging the intensity line profiles of multiple spots on glass and fitting the data to a Gaussian function. In this way we generated in-silico spots with a PSF and an amplitude equivalent to the values obtained from the Gaussian fits of the real data. For each cell, the total number of Siglec-1 molecules randomly distributed in a defined cell area was calculated according to the total number of spots (<italic>Z</italic>) quantified in the experimental data and the probability distributions (<italic>α<sub>n</sub></italic>) of <italic>n</italic> molecules per spot up to a maximum of <italic>N</italic> = 12 molecules per spot.<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mi>*</mml:mi><mml:mi>n</mml:mi><mml:mi>*</mml:mi><mml:mi>Z</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="s4-12"><title>Analysis of actin and Siglec-1 distribution</title><p>To correlate the intensities of Siglec-1 and cortical actin, we processed STED images for Siglec-1 as described in ‘Quantification of molecules per spot’. Then we measured the mean intensity profiles for each channel from the cell center to the edges in concentric radius of 1.3 pixels. Distance from the cell center was normalized as a percentage of the maximum cell radius for each cell, and intensities at each radius were normalized to the sum of all the intensities for all the radius.</p></sec><sec id="s4-13"><title>Under-agarose experiments</title><p>Under-agarose chemotaxis assays were performed as described elsewhere (<xref ref-type="bibr" rid="bib46">Kopf et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Lämmermann et al., 2009a</xref>). Briefly, we added ultrapure agarose (Invitrogen) at 4% to RPMI supplemented with 20% FBS and Hank buffered solution (GIBCO) at a 1:2:1 ratio. We poured 1 ml of the mixture on 35-mm glass coverslips previously coated with 30 µg/ml of fibronectin. After polymerization at RT we added 4 × 10<sup>5</sup> cells in 30 µl of RPMI between the agarose pad and the glass. We allowed the cells to equilibrate for about 15–30 min and then added on the borders of the agarose pad 1 ml of complete RPMI with 2.5 µg/ml of CCL19. After 90 min at 37°C we directly added to the cells 1 ml of PFA at 8% for 10 min. We gently lifted the agarose pad and processed the sample for immunostaining with SIR-actin and anti-Siglec-1. Two color STED images acquired as previously described were analyzed for the distribution of actin and Siglec-1 staining at the rear and the cell front. Briefly, we defined a 0 angle between the cell center and the center-of-mass of the uropod at the trailing edge, and quantified the percentage of Siglec-1 and actin staining in 40° binning. For the analysis of Siglec-1 molecules per spot, the receptors counted at the rear were all the spots at ±20° (from the 0 angle) and between 140° and 220° for the front.</p></sec><sec id="s4-14"><title>Confocal imaging</title><p>Confocal images on fixed DCs were obtained with a confocal microscope (Leica TCS SP8, Leica Microsystems) as specified in ‘STED images’. Images were acquired with a format of 1024 × 1024 pixels at 400 Hz with the pinhole set at 1.0 A.U. When performing 3D confocal imaging, the whole surface of cells was covered in stacks of 10–15 images from the basal to the apical membrane. We applied intensity thresholds for each staining and calculated the mean intensity values in axial planes of 1.5 µm. For each cell, the minimum mean intensity value within the stack was used to normalize the axial distribution of each staining. To measure the area of cells at different axial planes after VLP/LUV capture, we delimited the edges of cells stained with SiR-actin applying a binary mask for each plane and quantified the area enclosed in such perimeter.</p></sec><sec id="s4-15"><title>Sample preparation and analysis of Siglec-1 single-particle tracking in living cells</title><p>1 × 10<sup>6</sup> immature and LPS (100 ng/ml for 48 hr) matured DCs in suspension were incubated in complete RPMI supplemented with 10% FBS and 1 µg/ml of single-chain Siglec-1 antibodies on ice for 30 min, after which cells were washed three times in PBS and resuspended in 500 µl of complete RPMI. Next, cells were seeded on 35-mm glass coverslips (Corning) coated with poly-<sc>L</sc>-lysine at 30 µg/mL and after 30–60 min of adhesion at 37°C cells we added Fab-Atto488 anti-mouse antibodies at 1 µg/ml for 5 min. Cells were washed several times in PBS and covered with 1 ml of complete RPMI supplemented with 25 mM of HEPES.</p><p>Live imaging was done with a confocal microscope (see STED imaging) connected to a temperature control device at 37°C. For the detection of Fab-Atto488, samples were excited with a WLL laser at 488 nm (20% power) setting the emission range at 509–595 nm. Scan laser speed was set at 1000 Hz to record 3 frames per second in a format of 512 × 512 pixels.</p><p>The particle tracking analysis was done using the MOSAIC tool of Fiji (<xref ref-type="bibr" rid="bib74">Sbalzarini and Koumoutsakos, 2005</xref>). The implementation of the plugin requires the approximate particle radius <italic>w</italic> (in our case 3 pixels), the intensity percentile <italic>r</italic>, which is used to select among the local maxima pixels in a radius <italic>w</italic> the ones that have an intensity above the selected <italic>r</italic> value (in our case the upper 0.5 percentile), the cut-off intensity score <italic>Ts</italic> to remove those pixel values below a intensity threshold (in our case set to 0), the maximum displacement in pixels between contiguous frames (in our settings 5 pixels), and the number of future frames that can be considered to re-connect particles (in our case 2, which means that a single particle can disappear for just one frame to be re-connected with another particle in the next frame).</p><p>Individual trajectories of a minimum of 20 points were analyzed calculating their moments of displacement <italic>µ</italic><sub><italic>v</italic></sub>, which for a trajectory of a length <italic>M</italic><sub><italic>l</italic></sub> and a frame shift Δ<italic>n</italic>, corresponding to a time shift δ<italic>t</italic> = Δ<italic>n</italic>Δ<italic>t</italic>, is defined as:<disp-formula id="equ6"><mml:math id="m6"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mo>,</mml:mo><mml:mi>l</mml:mi><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mo>∆</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi> </mml:mi><mml:mo>∆</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mi> </mml:mi><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mo>∆</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msup><mml:mrow><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:math></disp-formula></p><p>where <italic>x<sub>l</sub></italic> is the position vector (<italic>x</italic>′(<italic>n</italic>), <italic>y</italic>′(<italic>n</italic>)) on an individual trajectory <italic>l</italic> at time <italic>n</italic>Δ<italic>t</italic>. To quantify the particle motion these moments are calculated for  <inline-formula><mml:math id="inf2"><mml:mi>v</mml:mi></mml:math></inline-formula> = 0, 1, 2,…, 6 and Δ<italic>n</italic> = 1, …, <italic>M</italic><sub><italic>l</italic>/3</sub>. For all the moments of displacement the scaling coefficients <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>ν</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are determined by a linear least squares regression to ln <italic>µ</italic><sub><italic>ʋ</italic></sub> versus ln δ<italic>t</italic>. The regular diffusion constant for <inline-formula><mml:math id="inf4"><mml:mi>ν</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:math></inline-formula> (<italic>D</italic><sub>2</sub>) was obtained from the <italic>y</italic><sub>0</sub> intercept of the regression line such as <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>4</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mi>*</mml:mi><mml:mi> </mml:mi><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:math></inline-formula> . To calculate the fraction of immobile particles, we measured the <italic>D</italic><sub>2</sub> values of fixed antibodies on glass acquired in the same imaging conditions as in the cells. We defined mobile particles as those whose <italic>D</italic><sub>2</sub> values were above the 90 percentile of the <italic>D</italic><sub>2</sub> values measured for the antibodies on glass (in our case 0.002 µm<sup>2</sup>/s). The slope of the plot of <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>ν</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> versus <inline-formula><mml:math id="inf7"><mml:mi>ν</mml:mi></mml:math></inline-formula>, called moment scale spectrum (MSS) was used to classify trajectories according to their motions in confined (&lt;0.2), sub-difussive (&gt;0.2 to &lt;0.5), and free (&gt;0.5).</p></sec><sec id="s4-16"><title>Statistical analysis</title><p>All results were analyzed using GraphPad PRISM 7.0 (ns, p &gt; R 0.05, *p % 0.05, **p % 0.001; ***p % 0.0001).</p><p>Paired <italic>T</italic>-test analysis was used in <xref ref-type="fig" rid="fig1">Figures 1C, D, G</xref>, <xref ref-type="fig" rid="fig2">2F, G, K,</xref>, <xref ref-type="fig" rid="fig6">6G, E</xref>.</p><p>Non-parametric Mann–Whitney tests were used in <xref ref-type="fig" rid="fig3">Figure 3H,I</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K,L,M</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B, C, E, J, M</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B, C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>, <xref ref-type="fig" rid="fig4">Figure 4B,C,D</xref>, <xref ref-type="fig" rid="fig6">Figure 6I</xref>.</p><p>Kruskal–Wallis with Dunn’s multiple comparison tests was used in <xref ref-type="fig" rid="fig4">Figures 4F, G, J</xref>, <xref ref-type="fig" rid="fig5">5E, F, H, I, J</xref>.</p><p>Two-way analysis of variance with multiple comparison Bonferroni tests was used in <xref ref-type="fig" rid="fig1">Figure 1B,H,J</xref>, <xref ref-type="fig" rid="fig2">Figure 2H,I,L</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C,E,I</xref>, <xref ref-type="fig" rid="fig3">Figure 3B, C, F, J, K</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F, G, H, K, L, N</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B, D</xref>, <xref ref-type="fig" rid="fig5">Figure 5B, C, D, G, K</xref>, <xref ref-type="fig" rid="fig6">Figure 6B-J</xref>.<xref ref-type="fig" rid="fig1">1</xref>—<xref ref-type="fig" rid="fig6">6</xref></p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf4"><p>declares patent applications related to the inhibition of viral interactions with Siglec-1. application reference EP23382072.9. The author declare no other competing interests</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Resources, Software, Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Writing – original draft</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Software, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-78836-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1–6 and for the corresponding figure supplements.</p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank C Martinez-Guillamon for initial experiments, J Andilla and M Marsal for technical support at the Super-resolution Light Nanoscopy (SLN) facility at ICFO. The research leading to these results has received funding from the European Commission H2020 Program (grant agreement ERC Adv788546 (NANO-MEMEC) (to MFG-P) and Marie Sklodowska-Curie grant 754558-PREBIST (to NM)), Government of Spain Severo Ochoa CEX2019-000910-S, State Research Agency (AEI) (PID2020-113068RB-I00/10.13039/501100011033 (to MFG-P), PID2019-109870RB-I00 (to JM-P), (PID2020-117405GB-100 to ML), RYC-2017-22227 (to FC), RYC-2015-17896 (to CM), and PID2019-106232RB-I00/10.13039/501100011033 (to FC)), Fundació CELLEX (Barcelona), Fundació Mir-Puig and the Generalitat de Catalunya through the CERCA program and AGAUR (Grant No. 2017SGR1000 to MFG-P). NI-U is supported by grant PID2020-117145RB-I00 from the Spanish Ministry of Science and Innovation. JM-P an NI-U are funded by the CIBER de Enfermedades Infecciosas.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Ramirez</surname><given-names>N-GP</given-names></name><name><surname>Gudheti</surname><given-names>MV</given-names></name><name><surname>Gummuluru</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies</article-title><source>PLOS Pathogens</source><volume>11</volume><elocation-id>e1004751</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004751</pub-id><pub-id pub-id-type="pmid">25760631</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>André</surname><given-names>F</given-names></name><name><surname>Chaput</surname><given-names>N</given-names></name><name><surname>Schartz</surname><given-names>NEC</given-names></name><name><surname>Flament</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>N</given-names></name><name><surname>Bernard</surname><given-names>J</given-names></name><name><surname>Lemonnier</surname><given-names>F</given-names></name><name><surname>Raposo</surname><given-names>G</given-names></name><name><surname>Escudier</surname><given-names>B</given-names></name><name><surname>Hsu</surname><given-names>DH</given-names></name><name><surname>Tursz</surname><given-names>T</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name><name><surname>Angevin</surname><given-names>E</given-names></name><name><surname>Zitvogel</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Exosomes as potent cell-free peptide-based vaccine. I. dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells</article-title><source>Journal of Immunology</source><volume>172</volume><fpage>2126</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.4.2126</pub-id><pub-id pub-id-type="pmid">14764678</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audoly</surname><given-names>G</given-names></name><name><surname>Popoff</surname><given-names>MR</given-names></name><name><surname>Gluschankof</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Involvement of a small GTP binding protein in HIV-1 release</article-title><source>Retrovirology</source><volume>2</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4690-2-48</pub-id><pub-id pub-id-type="pmid">16080789</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Dendritic cells and the control of immunity</article-title><source>Nature</source><volume>392</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/32588</pub-id><pub-id pub-id-type="pmid">9521319</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgart</surname><given-names>T</given-names></name><name><surname>Hess</surname><given-names>ST</given-names></name><name><surname>Webb</surname><given-names>WW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension</article-title><source>Nature</source><volume>425</volume><fpage>821</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1038/nature02013</pub-id><pub-id pub-id-type="pmid">14574408</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benet</surname><given-names>S</given-names></name><name><surname>Gálvez</surname><given-names>C</given-names></name><name><surname>Drobniewski</surname><given-names>F</given-names></name><name><surname>Kontsevaya</surname><given-names>I</given-names></name><name><surname>Arias</surname><given-names>L</given-names></name><name><surname>Monguió-Tortajada</surname><given-names>M</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Urrea</surname><given-names>V</given-names></name><name><surname>Ong</surname><given-names>RY</given-names></name><name><surname>Luquin</surname><given-names>M</given-names></name><name><surname>Dupont</surname><given-names>M</given-names></name><name><surname>Chojnacki</surname><given-names>J</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Cardona</surname><given-names>P</given-names></name><name><surname>Neyrolles</surname><given-names>O</given-names></name><name><surname>Lugo-Villarino</surname><given-names>G</given-names></name><name><surname>Vérollet</surname><given-names>C</given-names></name><name><surname>Julián</surname><given-names>E</given-names></name><name><surname>Furrer</surname><given-names>H</given-names></name><name><surname>Günthard</surname><given-names>HF</given-names></name><name><surname>Crocker</surname><given-names>PR</given-names></name><name><surname>Tapia</surname><given-names>G</given-names></name><name><surname>Borràs</surname><given-names>FE</given-names></name><name><surname>Fellay</surname><given-names>J</given-names></name><name><surname>McLaren</surname><given-names>PJ</given-names></name><name><surname>Telenti</surname><given-names>A</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Clotet</surname><given-names>B</given-names></name><name><surname>Vilaplana</surname><given-names>C</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles</article-title><source>Journal of Extracellular Vesicles</source><volume>10</volume><elocation-id>e12046</elocation-id><pub-id pub-id-type="doi">10.1002/jev2.12046</pub-id><pub-id pub-id-type="pmid">33489013</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornhöfft</surname><given-names>KF</given-names></name><name><surname>Goldammer</surname><given-names>T</given-names></name><name><surname>Rebl</surname><given-names>A</given-names></name><name><surname>Galuska</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Siglecs: a journey through the evolution of sialic acid-binding immunoglobulin-type lectins</article-title><source>Developmental and Comparative Immunology</source><volume>86</volume><fpage>219</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2018.05.008</pub-id><pub-id pub-id-type="pmid">29751010</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Böttcher</surname><given-names>CJF</given-names></name><name><surname>Van gent</surname><given-names>CM</given-names></name><name><surname>Pries</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>A rapid and sensitive sub-micro phosphorus determination</article-title><source>Analytica Chimica Acta</source><volume>24</volume><fpage>203</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/0003-2670(61)80041-X</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazzoli</surname><given-names>M</given-names></name><name><surname>Bianchi</surname><given-names>A</given-names></name><name><surname>Filippini</surname><given-names>S</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Pizza</surname><given-names>M</given-names></name><name><surname>Crotta</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cd81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes</article-title><source>Journal of Virology</source><volume>82</volume><fpage>8316</fpage><lpage>8329</lpage><pub-id pub-id-type="doi">10.1128/JVI.00665-08</pub-id><pub-id pub-id-type="pmid">18579606</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>Schacker</surname><given-names>TW</given-names></name><name><surname>Asher</surname><given-names>TE</given-names></name><name><surname>Silvestri</surname><given-names>G</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Kazzaz</surname><given-names>Z</given-names></name><name><surname>Bornstein</surname><given-names>E</given-names></name><name><surname>Lambotte</surname><given-names>O</given-names></name><name><surname>Altmann</surname><given-names>D</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name><name><surname>Teixeira-Johnson</surname><given-names>L</given-names></name><name><surname>Landay</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>JN</given-names></name><name><surname>Hecht</surname><given-names>FM</given-names></name><name><surname>Picker</surname><given-names>LJ</given-names></name><name><surname>Lederman</surname><given-names>MM</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Microbial translocation is a cause of systemic immune activation in chronic HIV infection</article-title><source>Nature Medicine</source><volume>12</volume><fpage>1365</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1038/nm1511</pub-id><pub-id pub-id-type="pmid">17115046</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brügger</surname><given-names>B</given-names></name><name><surname>Glass</surname><given-names>B</given-names></name><name><surname>Haberkant</surname><given-names>P</given-names></name><name><surname>Leibrecht</surname><given-names>I</given-names></name><name><surname>Wieland</surname><given-names>FT</given-names></name><name><surname>Kräusslich</surname><given-names>HG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The HIV lipidome: a raft with an unusual composition</article-title><source>PNAS</source><volume>103</volume><fpage>2641</fpage><lpage>2646</lpage><pub-id pub-id-type="doi">10.1073/pnas.0511136103</pub-id><pub-id pub-id-type="pmid">16481622</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambi</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>F</given-names></name><name><surname>van Maarseveen</surname><given-names>NM</given-names></name><name><surname>Nijhuis</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>B</given-names></name><name><surname>van Dijk</surname><given-names>EMHP</given-names></name><name><surname>de Bakker</surname><given-names>BI</given-names></name><name><surname>Fransen</surname><given-names>JAM</given-names></name><name><surname>Bovee-Geurts</surname><given-names>PHM</given-names></name><name><surname>van Leeuwen</surname><given-names>FN</given-names></name><name><surname>Van Hulst</surname><given-names>NF</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells</article-title><source>The Journal of Cell Biology</source><volume>164</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1083/jcb.200306112</pub-id><pub-id pub-id-type="pmid">14709546</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Forsum</surname><given-names>U</given-names></name><name><surname>Teppler</surname><given-names>H</given-names></name><name><surname>Granelli-Piperno</surname><given-names>A</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1992">1992a</year><article-title>During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion</article-title><source>Clinical and Experimental Immunology</source><volume>88</volume><fpage>226</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.1992.tb03066.x</pub-id><pub-id pub-id-type="pmid">1349271</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Freudenthal</surname><given-names>PS</given-names></name><name><surname>Barker</surname><given-names>JM</given-names></name><name><surname>Gezelter</surname><given-names>S</given-names></name><name><surname>Inaba</surname><given-names>K</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1992">1992b</year><article-title>Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells</article-title><source>Science</source><volume>257</volume><fpage>383</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1126/science.1352913</pub-id><pub-id pub-id-type="pmid">1352913</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>R</given-names></name><name><surname>Uchil</surname><given-names>PD</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Shui</surname><given-names>G</given-names></name><name><surname>Ott</surname><given-names>DE</given-names></name><name><surname>Mothes</surname><given-names>W</given-names></name><name><surname>Wenk</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides</article-title><source>Journal of Virology</source><volume>82</volume><fpage>11228</fpage><lpage>11238</lpage><pub-id pub-id-type="doi">10.1128/JVI.00981-08</pub-id><pub-id pub-id-type="pmid">18799574</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaput</surname><given-names>N</given-names></name><name><surname>Schartz</surname><given-names>NEC</given-names></name><name><surname>André</surname><given-names>F</given-names></name><name><surname>Taïeb</surname><given-names>J</given-names></name><name><surname>Novault</surname><given-names>S</given-names></name><name><surname>Bonnaventure</surname><given-names>P</given-names></name><name><surname>Aubert</surname><given-names>N</given-names></name><name><surname>Bernard</surname><given-names>J</given-names></name><name><surname>Lemonnier</surname><given-names>F</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Adema</surname><given-names>G</given-names></name><name><surname>Adams</surname><given-names>M</given-names></name><name><surname>Ferrantini</surname><given-names>M</given-names></name><name><surname>Carpentier</surname><given-names>AF</given-names></name><name><surname>Escudier</surname><given-names>B</given-names></name><name><surname>Tursz</surname><given-names>T</given-names></name><name><surname>Angevin</surname><given-names>E</given-names></name><name><surname>Zitvogel</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Exosomes as potent cell-free peptide-based vaccine. II. exosomes in cpg adjuvants efficiently prime naive tc1 lymphocytes leading to tumor rejection</article-title><source>Journal of Immunology</source><volume>172</volume><fpage>2137</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.4.2137</pub-id><pub-id pub-id-type="pmid">14764679</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crocker</surname><given-names>PR</given-names></name><name><surname>Paulson</surname><given-names>JC</given-names></name><name><surname>Varki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Siglecs and their roles in the immune system</article-title><source>Nature Reviews. Immunology</source><volume>7</volume><fpage>255</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1038/nri2056</pub-id><pub-id pub-id-type="pmid">17380156</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>BI</given-names></name><name><surname>de Lange</surname><given-names>F</given-names></name><name><surname>Cambi</surname><given-names>A</given-names></name><name><surname>Korterik</surname><given-names>JP</given-names></name><name><surname>van Dijk</surname><given-names>EMHP</given-names></name><name><surname>van Hulst</surname><given-names>NF</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy</article-title><source>Chemphyschem</source><volume>8</volume><fpage>1473</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1002/cphc.200700169</pub-id><pub-id pub-id-type="pmid">17577901</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaguillaumie</surname><given-names>A</given-names></name><name><surname>Lagaudrière-Gesbert</surname><given-names>C</given-names></name><name><surname>Popoff</surname><given-names>MR</given-names></name><name><surname>Conjeaud</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Rho gtpases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes</article-title><source>Journal of Cell Science</source><volume>115</volume><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1242/jcs.115.2.433</pub-id><pub-id pub-id-type="pmid">11839793</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaguillaumie</surname><given-names>A</given-names></name><name><surname>Harriague</surname><given-names>J</given-names></name><name><surname>Kohanna</surname><given-names>S</given-names></name><name><surname>Bismuth</surname><given-names>G</given-names></name><name><surname>Rubinstein</surname><given-names>E</given-names></name><name><surname>Seigneuret</surname><given-names>M</given-names></name><name><surname>Conjeaud</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>5269</fpage><lpage>5282</lpage><pub-id pub-id-type="doi">10.1242/jcs.01380</pub-id><pub-id pub-id-type="pmid">15454569</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharan</surname><given-names>R</given-names></name><name><surname>Goren</surname><given-names>S</given-names></name><name><surname>Cheppali</surname><given-names>SK</given-names></name><name><surname>Shendrik</surname><given-names>P</given-names></name><name><surname>Brand</surname><given-names>G</given-names></name><name><surname>Vaknin</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Kozlov</surname><given-names>MM</given-names></name><name><surname>Sorkin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Transmembrane proteins tetraspanin 4 and CD9 sense membrane curvature</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2208993119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2208993119</pub-id><pub-id pub-id-type="pmid">36252000</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharan</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Cheppali</surname><given-names>SK</given-names></name><name><surname>Goren</surname><given-names>S</given-names></name><name><surname>Shendrik</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Kozlov</surname><given-names>MM</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Sorkin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Tetraspanin 4 stabilizes membrane swellings and facilitates their maturation into migrasomes</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>1037</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-36596-9</pub-id><pub-id pub-id-type="pmid">36823145</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>P-X</given-names></name><name><surname>O’Rourke</surname><given-names>TK</given-names></name><name><surname>Murray</surname><given-names>TS</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Britto</surname><given-names>CJ</given-names></name><name><surname>Koff</surname><given-names>JL</given-names></name><name><surname>Krause</surname><given-names>DS</given-names></name><name><surname>Egan</surname><given-names>ME</given-names></name><name><surname>Bruscia</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>10882</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-11012-7</pub-id><pub-id pub-id-type="pmid">28883468</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felts</surname><given-names>RL</given-names></name><name><surname>Narayan</surname><given-names>K</given-names></name><name><surname>Estes</surname><given-names>JD</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Trubey</surname><given-names>CM</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Hartnell</surname><given-names>LM</given-names></name><name><surname>Ruthel</surname><given-names>GT</given-names></name><name><surname>Schneider</surname><given-names>DK</given-names></name><name><surname>Nagashima</surname><given-names>K</given-names></name><name><surname>Bess</surname><given-names>JW</given-names></name><name><surname>Bavari</surname><given-names>S</given-names></name><name><surname>Lowekamp</surname><given-names>BC</given-names></name><name><surname>Bliss</surname><given-names>D</given-names></name><name><surname>Lifson</surname><given-names>JD</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells</article-title><source>PNAS</source><volume>107</volume><fpage>13336</fpage><lpage>13341</lpage><pub-id pub-id-type="doi">10.1073/pnas.1003040107</pub-id><pub-id pub-id-type="pmid">20624966</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>R</given-names></name><name><surname>Manfroi</surname><given-names>AJ</given-names></name><name><surname>Young</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Strongly and weakly self-similar diffusion</article-title><source>Physica D</source><volume>154</volume><fpage>111</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/S0167-2789(01)00234-2</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>SA</given-names></name><name><surname>Vega</surname><given-names>A</given-names></name><name><surname>Riedl</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>RF</given-names></name><name><surname>Ostrowski</surname><given-names>PP</given-names></name><name><surname>Woods</surname><given-names>EC</given-names></name><name><surname>Bertozzi</surname><given-names>CR</given-names></name><name><surname>Tammi</surname><given-names>MI</given-names></name><name><surname>Lidke</surname><given-names>DS</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><name><surname>Mayor</surname><given-names>S</given-names></name><name><surname>Jaqaman</surname><given-names>K</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transmembrane pickets connect cyto- and pericellular skeletons forming barriers to receptor engagement</article-title><source>Cell</source><volume>172</volume><fpage>305</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.023</pub-id><pub-id pub-id-type="pmid">29328918</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>E</given-names></name><name><surname>Pion</surname><given-names>M</given-names></name><name><surname>Pelchen-Matthews</surname><given-names>A</given-names></name><name><surname>Collinson</surname><given-names>L</given-names></name><name><surname>Arrighi</surname><given-names>JF</given-names></name><name><surname>Blot</surname><given-names>G</given-names></name><name><surname>Leuba</surname><given-names>F</given-names></name><name><surname>Escola</surname><given-names>JM</given-names></name><name><surname>Demaurex</surname><given-names>N</given-names></name><name><surname>Marsh</surname><given-names>M</given-names></name><name><surname>Piguet</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hiv-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse</article-title><source>Traffic</source><volume>6</volume><fpage>488</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00293.x</pub-id><pub-id pub-id-type="pmid">15882445</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladnikoff</surname><given-names>M</given-names></name><name><surname>Shimoni</surname><given-names>E</given-names></name><name><surname>Gov</surname><given-names>NS</given-names></name><name><surname>Rousso</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Retroviral assembly and budding occur through an actin-driven mechanism</article-title><source>Biophysical Journal</source><volume>97</volume><fpage>2419</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2009.08.016</pub-id><pub-id pub-id-type="pmid">19883584</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MR</given-names></name><name><surname>Reth</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Antigen receptor function in the context of the nanoscale organization of the B cell membrane</article-title><source>Annual Review of Immunology</source><volume>37</volume><fpage>97</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042718-041704</pub-id><pub-id pub-id-type="pmid">31026412</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granelli-Piperno</surname><given-names>A</given-names></name><name><surname>Moser</surname><given-names>B</given-names></name><name><surname>Pope</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Isdell</surname><given-names>F</given-names></name><name><surname>O’Doherty</surname><given-names>U</given-names></name><name><surname>Paxton</surname><given-names>W</given-names></name><name><surname>Koup</surname><given-names>R</given-names></name><name><surname>Mojsov</surname><given-names>S</given-names></name><name><surname>Bhardwaj</surname><given-names>N</given-names></name><name><surname>Clark-Lewis</surname><given-names>I</given-names></name><name><surname>Baggiolini</surname><given-names>M</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors</article-title><source>The Journal of Experimental Medicine</source><volume>184</volume><fpage>2433</fpage><lpage>2438</lpage><pub-id pub-id-type="doi">10.1084/jem.184.6.2433</pub-id><pub-id pub-id-type="pmid">8976200</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granelli-Piperno</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>E</given-names></name><name><surname>Finkel</surname><given-names>V</given-names></name><name><surname>Paxton</surname><given-names>W</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both m- and T-tropic virus to T cells</article-title><source>Journal of Virology</source><volume>72</volume><fpage>2733</fpage><lpage>2737</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.4.2733-2737.1998</pub-id><pub-id pub-id-type="pmid">9525591</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granelli-Piperno</surname><given-names>A</given-names></name><name><surname>Finkel</surname><given-names>V</given-names></name><name><surname>Delgado</surname><given-names>E</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells</article-title><source>Current Biology</source><volume>9</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(99)80043-8</pub-id><pub-id pub-id-type="pmid">9889121</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammonds</surname><given-names>JE</given-names></name><name><surname>Beeman</surname><given-names>N</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Takushi</surname><given-names>S</given-names></name><name><surname>Francis</surname><given-names>AC</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Melikyan</surname><given-names>GB</given-names></name><name><surname>Spearman</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006181</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006181</pub-id><pub-id pub-id-type="pmid">28129379</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmon</surname><given-names>B</given-names></name><name><surname>Campbell</surname><given-names>N</given-names></name><name><surname>Ratner</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Role of abl kinase and the WAVE2 signaling complex in HIV-1 entry at a post-hemifusion step</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1000956</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000956</pub-id><pub-id pub-id-type="pmid">20585556</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>JY</given-names></name><name><surname>Reuter</surname><given-names>MA</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells</article-title><source>PLOS Pathogens</source><volume>4</volume><elocation-id>e1000134</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000134</pub-id><pub-id pub-id-type="pmid">18725936</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Hildreth</surname><given-names>JEK</given-names></name><name><surname>Schwartz</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Actin-Dependent receptor colocalization required for human immunodeficiency virus entry into host cells</article-title><source>Journal of Virology</source><volume>72</volume><fpage>5251</fpage><lpage>5255</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.6.5251-5255.1998</pub-id><pub-id pub-id-type="pmid">9573299</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Fernández-Figueras</surname><given-names>MT</given-names></name><name><surname>Borràs</surname><given-names>FE</given-names></name><name><surname>Naranjo-Gómez</surname><given-names>M</given-names></name><name><surname>Bofill</surname><given-names>M</given-names></name><name><surname>Ruiz</surname><given-names>L</given-names></name><name><surname>Clotet</surname><given-names>B</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission</article-title><source>Journal of Virology</source><volume>81</volume><fpage>7559</fpage><lpage>7570</lpage><pub-id pub-id-type="doi">10.1128/JVI.02572-06</pub-id><pub-id pub-id-type="pmid">17475656</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name><name><surname>Esteban</surname><given-names>O</given-names></name><name><surname>Rodriguez-Plata</surname><given-names>MT</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Prado</surname><given-names>JG</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>García-Parajo</surname><given-names>MF</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells</article-title><source>Traffic</source><volume>12</volume><fpage>1702</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2011.01281.x</pub-id><pub-id pub-id-type="pmid">21917091</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name><name><surname>Lorizate</surname><given-names>M</given-names></name><name><surname>Contreras</surname><given-names>FX</given-names></name><name><surname>Rodriguez-Plata</surname><given-names>MT</given-names></name><name><surname>Glass</surname><given-names>B</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Prado</surname><given-names>JG</given-names></name><name><surname>Casas</surname><given-names>J</given-names></name><name><surname>Fabriàs</surname><given-names>G</given-names></name><name><surname>Kräusslich</surname><given-names>HG</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1</article-title><source>PLOS Biology</source><volume>10</volume><elocation-id>e1001315</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001315</pub-id><pub-id pub-id-type="pmid">22545022</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name><name><surname>Lorizate</surname><given-names>M</given-names></name><name><surname>Puertas</surname><given-names>MC</given-names></name><name><surname>Rodriguez-Plata</surname><given-names>MT</given-names></name><name><surname>Zangger</surname><given-names>N</given-names></name><name><surname>Erikson</surname><given-names>E</given-names></name><name><surname>Pino</surname><given-names>M</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Glass</surname><given-names>B</given-names></name><name><surname>Clotet</surname><given-names>B</given-names></name><name><surname>Keppler</surname><given-names>OT</given-names></name><name><surname>Telenti</surname><given-names>A</given-names></name><name><surname>Kräusslich</surname><given-names>HG</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides</article-title><source>PLOS Biology</source><volume>10</volume><elocation-id>e1001448</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001448</pub-id><pub-id pub-id-type="pmid">23271952</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>CM</given-names></name><name><surname>Zwick</surname><given-names>DB</given-names></name><name><surname>Grim</surname><given-names>JC</given-names></name><name><surname>Alam</surname><given-names>MM</given-names></name><name><surname>Prost</surname><given-names>LR</given-names></name><name><surname>Gardiner</surname><given-names>JC</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Zimdars</surname><given-names>LL</given-names></name><name><surname>Sherer</surname><given-names>NM</given-names></name><name><surname>Kiessling</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Antigen structure affects cellular routing through DC-SIGN</article-title><source>PNAS</source><volume>116</volume><fpage>14862</fpage><lpage>14867</lpage><pub-id pub-id-type="doi">10.1073/pnas.1820165116</pub-id><pub-id pub-id-type="pmid">31270240</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Mitar</surname><given-names>I</given-names></name><name><surname>Sattentau</surname><given-names>QJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1</article-title><source>Journal of Virology</source><volume>81</volume><fpage>5547</fpage><lpage>5560</lpage><pub-id pub-id-type="doi">10.1128/JVI.01469-06</pub-id><pub-id pub-id-type="pmid">17360745</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>EL</given-names></name><name><surname>Wee</surname><given-names>JL</given-names></name><name><surname>Demaria</surname><given-names>MC</given-names></name><name><surname>Blakeley</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>PK</given-names></name><name><surname>Vega-Ramos</surname><given-names>J</given-names></name><name><surname>Villadangos</surname><given-names>JA</given-names></name><name><surname>van Spriel</surname><given-names>AB</given-names></name><name><surname>Hickey</surname><given-names>MJ</given-names></name><name><surname>Hämmerling</surname><given-names>GJ</given-names></name><name><surname>Wright</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dendritic cell migration and antigen presentation are coordinated by the opposing functions of the tetraspanins CD82 and CD37</article-title><source>Journal of Immunology</source><volume>196</volume><fpage>978</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500357</pub-id><pub-id pub-id-type="pmid">26729805</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalay</surname><given-names>Z</given-names></name><name><surname>Fujiwara</surname><given-names>TK</given-names></name><name><surname>Otaka</surname><given-names>A</given-names></name><name><surname>Kusumi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lateral diffusion in a discrete fluid membrane with immobile particles</article-title><source>Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics</source><volume>89</volume><elocation-id>022724</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevE.89.022724</pub-id><pub-id pub-id-type="pmid">25353525</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerviel</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Chaloin</surname><given-names>L</given-names></name><name><surname>Favard</surname><given-names>C</given-names></name><name><surname>Muriaux</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Virus assembly and plasma membrane domains: which came first?</article-title><source>Virus Research</source><volume>171</volume><fpage>332</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.08.014</pub-id><pub-id pub-id-type="pmid">22989508</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopf</surname><given-names>A</given-names></name><name><surname>Renkawitz</surname><given-names>J</given-names></name><name><surname>Hauschild</surname><given-names>R</given-names></name><name><surname>Girkontaite</surname><given-names>I</given-names></name><name><surname>Tedford</surname><given-names>K</given-names></name><name><surname>Merrin</surname><given-names>J</given-names></name><name><surname>Thorn-Seshold</surname><given-names>O</given-names></name><name><surname>Trauner</surname><given-names>D</given-names></name><name><surname>Häcker</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>KD</given-names></name><name><surname>Kiermaier</surname><given-names>E</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microtubules control cellular shape and coherence in amoeboid migrating cells</article-title><source>The Journal of Cell Biology</source><volume>219</volume><elocation-id>e201907154</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.201907154</pub-id><pub-id pub-id-type="pmid">32379884</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusumi</surname><given-names>A</given-names></name><name><surname>Fujiwara</surname><given-names>TK</given-names></name><name><surname>Chadda</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Tsunoyama</surname><given-names>TA</given-names></name><name><surname>Kalay</surname><given-names>Z</given-names></name><name><surname>Kasai</surname><given-names>RS</given-names></name><name><surname>Suzuki</surname><given-names>KGN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dynamic organizing principles of the plasma membrane that regulate signal transduction: commemorating the fortieth anniversary of Singer and nicolson’s fluid-mosaic model</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>28</volume><fpage>215</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100809-151736</pub-id><pub-id pub-id-type="pmid">22905956</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>DS</given-names></name><name><surname>Gregorio</surname><given-names>G</given-names></name><name><surname>Bitton</surname><given-names>N</given-names></name><name><surname>Hendrickson</surname><given-names>WA</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection</article-title><source>Immunity</source><volume>16</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(02)00259-5</pub-id><pub-id pub-id-type="pmid">11825572</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lämmermann</surname><given-names>T</given-names></name><name><surname>Renkawitz</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Hirsch</surname><given-names>K</given-names></name><name><surname>Brakebusch</surname><given-names>C</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Cdc42-Dependent leading edge coordination is essential for interstitial dendritic cell migration</article-title><source>Blood</source><volume>113</volume><fpage>5703</fpage><lpage>5710</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-11-191882</pub-id><pub-id pub-id-type="pmid">19190242</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lämmermann</surname><given-names>T</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Mechanical modes of amoeboid cell migration</article-title><source>Current Opinion in Cell Biology</source><volume>21</volume><fpage>636</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2009.05.003</pub-id><pub-id pub-id-type="pmid">19523798</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>ZP</given-names></name><name><surname>Zeng</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>XE</given-names></name><name><surname>Cui</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Particle tracking of human immunodeficiency virus type 1 productive entry into human primary macrophages</article-title><source>ACS Nano</source><volume>11</volume><fpage>3890</fpage><lpage>3903</lpage><pub-id pub-id-type="doi">10.1021/acsnano.7b00275</pub-id><pub-id pub-id-type="pmid">28371581</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipowsky</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Budding of membranes induced by intramembrane domains</article-title><source>Journal de Physique II</source><volume>2</volume><fpage>1825</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.1051/jp2:1992238</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kaksonen</surname><given-names>M</given-names></name><name><surname>Drubin</surname><given-names>DG</given-names></name><name><surname>Oster</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Endocytic vesicle scission by lipid phase boundary forces</article-title><source>PNAS</source><volume>103</volume><fpage>10277</fpage><lpage>10282</lpage><pub-id pub-id-type="doi">10.1073/pnas.0601045103</pub-id><pub-id pub-id-type="pmid">16801551</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Belkina</surname><given-names>NV</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Nambiar</surname><given-names>R</given-names></name><name><surname>Loughhead</surname><given-names>SM</given-names></name><name><surname>Patino-Lopez</surname><given-names>G</given-names></name><name><surname>Ben-Aissa</surname><given-names>K</given-names></name><name><surname>Hao</surname><given-names>J-J</given-names></name><name><surname>Kruhlak</surname><given-names>MJ</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name><name><surname>Kehrl</surname><given-names>JH</given-names></name><name><surname>Tyska</surname><given-names>MJ</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice</article-title><source>Blood</source><volume>119</volume><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-07-368860</pub-id><pub-id pub-id-type="pmid">22106344</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WM</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Moshiach</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>K</given-names></name><name><surname>Khurana</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Lahti</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>XA</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e51797</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0051797</pub-id><pub-id pub-id-type="pmid">23251627</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Manzo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>DECO</data-title><version designator="v1.0">v1.0</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/cmanzo/DECO">https://github.com/cmanzo/DECO</ext-link></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Muñoz</surname><given-names>L</given-names></name><name><surname>Rodríguez-Frade</surname><given-names>JM</given-names></name><name><surname>Barroso</surname><given-names>R</given-names></name><name><surname>Sorzano</surname><given-names>CÓS</given-names></name><name><surname>Torreño-Pina</surname><given-names>JA</given-names></name><name><surname>Santiago</surname><given-names>CA</given-names></name><name><surname>Manzo</surname><given-names>C</given-names></name><name><surname>Lucas</surname><given-names>P</given-names></name><name><surname>García-Cuesta</surname><given-names>EM</given-names></name><name><surname>Gutierrez</surname><given-names>E</given-names></name><name><surname>Barrio</surname><given-names>L</given-names></name><name><surname>Vargas</surname><given-names>J</given-names></name><name><surname>Cascio</surname><given-names>G</given-names></name><name><surname>Carrasco</surname><given-names>YR</given-names></name><name><surname>Sánchez-Madrid</surname><given-names>F</given-names></name><name><surname>García-Parajo</surname><given-names>MF</given-names></name><name><surname>Mellado</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Separating actin-dependent chemokine receptor nanoclustering from dimerization indicates a role for clustering in CXCR4 signaling and function</article-title><source>Molecular Cell</source><volume>70</volume><fpage>106</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.034</pub-id><pub-id pub-id-type="pmid">29625032</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>LD</given-names></name><name><surname>Hope</surname><given-names>MJ</given-names></name><name><surname>Cullis</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Vesicles of variable sizes produced by a rapid extrusion procedure</article-title><source>Biochimica et Biophysica Acta</source><volume>858</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/0005-2736(86)90302-0</pub-id><pub-id pub-id-type="pmid">3707960</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ménager</surname><given-names>MM</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Actin dynamics regulates dendritic cell-mediated transfer of HIV-1 to T cells</article-title><source>Cell</source><volume>164</volume><fpage>695</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.036</pub-id><pub-id pub-id-type="pmid">26830877</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>J</given-names></name><name><surname>Ziegler</surname><given-names>K</given-names></name><name><surname>Gelléri</surname><given-names>M</given-names></name><name><surname>Fröhlich-Nowoisky</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Bellinghausen</surname><given-names>I</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Birk</surname><given-names>U</given-names></name><name><surname>Pöschl</surname><given-names>U</given-names></name><name><surname>Cremer</surname><given-names>C</given-names></name><name><surname>Lucas</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nanoscale distribution of TLR4 on primary human macrophages stimulated with LPS and ATI</article-title><source>Nanoscale</source><volume>11</volume><fpage>9769</fpage><lpage>9779</lpage><pub-id pub-id-type="doi">10.1039/c9nr00943d</pub-id><pub-id pub-id-type="pmid">31066732</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolic</surname><given-names>DS</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Felts</surname><given-names>R</given-names></name><name><surname>Garcia</surname><given-names>E</given-names></name><name><surname>Blanchet</surname><given-names>FP</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name><name><surname>Piguet</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HIV-1 activates cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation</article-title><source>Blood</source><volume>118</volume><fpage>4841</fpage><lpage>4852</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-09-305417</pub-id><pub-id pub-id-type="pmid">21562048</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitschké</surname><given-names>M</given-names></name><name><surname>Aebischer</surname><given-names>D</given-names></name><name><surname>Abadier</surname><given-names>M</given-names></name><name><surname>Haener</surname><given-names>S</given-names></name><name><surname>Lucic</surname><given-names>M</given-names></name><name><surname>Vigl</surname><given-names>B</given-names></name><name><surname>Luche</surname><given-names>H</given-names></name><name><surname>Fehling</surname><given-names>HJ</given-names></name><name><surname>Biehlmaier</surname><given-names>O</given-names></name><name><surname>Lyck</surname><given-names>R</given-names></name><name><surname>Halin</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential requirement for ROCK in dendritic cell migration within lymphatic capillaries in steady-state and inflammation</article-title><source>Blood</source><volume>120</volume><fpage>2249</fpage><lpage>2258</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-03-417923</pub-id><pub-id pub-id-type="pmid">22855606</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odintsova</surname><given-names>E</given-names></name><name><surname>Butters</surname><given-names>TD</given-names></name><name><surname>Monti</surname><given-names>E</given-names></name><name><surname>Sprong</surname><given-names>H</given-names></name><name><surname>van Meer</surname><given-names>G</given-names></name><name><surname>Berditchevski</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Gangliosides play an important role in the organization of CD82-enriched microdomains</article-title><source>The Biochemical Journal</source><volume>400</volume><fpage>315</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1042/BJ20060259</pub-id><pub-id pub-id-type="pmid">16859490</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paluch</surname><given-names>EK</given-names></name><name><surname>Aspalter</surname><given-names>IM</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Focal adhesion-independent cell migration</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>32</volume><fpage>469</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-111315-125341</pub-id><pub-id pub-id-type="pmid">27501447</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Zsolt</surname><given-names>D</given-names></name><name><surname>Erkizia</surname><given-names>I</given-names></name><name><surname>Pino</surname><given-names>M</given-names></name><name><surname>García-Gallo</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>MT</given-names></name><name><surname>Benet</surname><given-names>S</given-names></name><name><surname>Chojnacki</surname><given-names>J</given-names></name><name><surname>Fernández-Figueras</surname><given-names>MT</given-names></name><name><surname>Guerrero</surname><given-names>D</given-names></name><name><surname>Urrea</surname><given-names>V</given-names></name><name><surname>Muñiz-Trabudua</surname><given-names>X</given-names></name><name><surname>Kremer</surname><given-names>L</given-names></name><name><surname>Martinez-Picado</surname><given-names>J</given-names></name><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Anti-siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>1558</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0453-2</pub-id><pub-id pub-id-type="pmid">31160823</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>M</given-names></name><name><surname>Betjes</surname><given-names>MGH</given-names></name><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Hirmand</surname><given-names>H</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Hoffman</surname><given-names>L</given-names></name><name><surname>Gezelter</surname><given-names>S</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1</article-title><source>Cell</source><volume>78</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90418-9</pub-id><pub-id pub-id-type="pmid">7914836</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>M</given-names></name><name><surname>Gezelter</surname><given-names>S</given-names></name><name><surname>Gallo</surname><given-names>N</given-names></name><name><surname>Hoffman</surname><given-names>L</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells</article-title><source>The Journal of Experimental Medicine</source><volume>182</volume><fpage>2045</fpage><lpage>2056</lpage><pub-id pub-id-type="doi">10.1084/jem.182.6.2045</pub-id><pub-id pub-id-type="pmid">7500050</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puryear</surname><given-names>WB</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Ramirez</surname><given-names>NP</given-names></name><name><surname>Reinhard</surname><given-names>BM</given-names></name><name><surname>Gummuluru</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hiv-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells</article-title><source>PNAS</source><volume>109</volume><fpage>7475</fpage><lpage>7480</lpage><pub-id pub-id-type="doi">10.1073/pnas.1201104109</pub-id><pub-id pub-id-type="pmid">22529395</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puryear</surname><given-names>WB</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Geer</surname><given-names>SD</given-names></name><name><surname>Ramirez</surname><given-names>NP</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Reinhard</surname><given-names>BM</given-names></name><name><surname>Gummuluru</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on siglec-1/CD169</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003291</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003291</pub-id><pub-id pub-id-type="pmid">23593001</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottner</surname><given-names>K</given-names></name><name><surname>Faix</surname><given-names>J</given-names></name><name><surname>Bogdan</surname><given-names>S</given-names></name><name><surname>Linder</surname><given-names>S</given-names></name><name><surname>Kerkhoff</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Actin assembly mechanisms at a glance</article-title><source>Journal of Cell Science</source><volume>130</volume><fpage>3427</fpage><lpage>3435</lpage><pub-id pub-id-type="doi">10.1242/jcs.206433</pub-id><pub-id pub-id-type="pmid">29032357</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouven Brückner</surname><given-names>B</given-names></name><name><surname>Pietuch</surname><given-names>A</given-names></name><name><surname>Nehls</surname><given-names>S</given-names></name><name><surname>Rother</surname><given-names>J</given-names></name><name><surname>Janshoff</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ezrin is a major regulator of membrane tension in epithelial cells</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>14700</elocation-id><pub-id pub-id-type="doi">10.1038/srep14700</pub-id><pub-id pub-id-type="pmid">26435322</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>Y</given-names></name><name><surname>Yuda</surname><given-names>Y</given-names></name><name><surname>Nonomura</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Myosin-Actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells</article-title><source>PNAS</source><volume>92</volume><fpage>2026</fpage><lpage>2030</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.6.2026</pub-id><pub-id pub-id-type="pmid">7892219</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunderson</surname><given-names>SC</given-names></name><name><surname>Dunn</surname><given-names>AC</given-names></name><name><surname>Crocker</surname><given-names>PR</given-names></name><name><surname>McLellan</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cd169 mediates the capture of exosomes in spleen and lymph node</article-title><source>Blood</source><volume>123</volume><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-489732</pub-id><pub-id pub-id-type="pmid">24255917</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sbalzarini</surname><given-names>IF</given-names></name><name><surname>Koumoutsakos</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Feature point tracking and trajectory analysis for video imaging in cell biology</article-title><source>Journal of Structural Biology</source><volume>151</volume><fpage>182</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2005.06.002</pub-id><pub-id pub-id-type="pmid">16043363</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Schütz</surname><given-names>GJ</given-names></name><name><surname>Gruber</surname><given-names>HJ</given-names></name><name><surname>Schindler</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Local stoichiometries determined by counting individual molecules</article-title><source>Analytical Chemistry</source><volume>68</volume><fpage>4397</fpage><lpage>4401</lpage><pub-id pub-id-type="doi">10.1021/ac960710g</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura</surname><given-names>E</given-names></name><name><surname>Guérin</surname><given-names>C</given-names></name><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name><name><surname>Théry</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cd8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo</article-title><source>Journal of Immunology</source><volume>179</volume><fpage>1489</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.3.1489</pub-id><pub-id pub-id-type="pmid">17641014</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>E</given-names></name><name><surname>Barr</surname><given-names>V</given-names></name><name><surname>Manley</surname><given-names>S</given-names></name><name><surname>Patterson</surname><given-names>G</given-names></name><name><surname>Balagopalan</surname><given-names>L</given-names></name><name><surname>Akpan</surname><given-names>I</given-names></name><name><surname>Regan</surname><given-names>CK</given-names></name><name><surname>Merrill</surname><given-names>RK</given-names></name><name><surname>Sommers</surname><given-names>CL</given-names></name><name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name><name><surname>Samelson</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor</article-title><source>Immunity</source><volume>35</volume><fpage>705</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.10.004</pub-id><pub-id pub-id-type="pmid">22055681</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>A</given-names></name><name><surname>Prasad</surname><given-names>A</given-names></name><name><surname>Kuzontkoski</surname><given-names>PM</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Groopman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Slit2N inhibits transmission of HIV-1 from dendritic cells to T-cells by modulating novel cytoskeletal elements</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>16833</elocation-id><pub-id pub-id-type="doi">10.1038/srep16833</pub-id><pub-id pub-id-type="pmid">26582347</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sil</surname><given-names>P</given-names></name><name><surname>Mateos</surname><given-names>N</given-names></name><name><surname>Nath</surname><given-names>S</given-names></name><name><surname>Buschow</surname><given-names>S</given-names></name><name><surname>Manzo</surname><given-names>C</given-names></name><name><surname>Suzuki</surname><given-names>KGN</given-names></name><name><surname>Fujiwara</surname><given-names>T</given-names></name><name><surname>Kusumi</surname><given-names>A</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name><name><surname>Mayor</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamic actin-mediated nano-scale clustering of CD44 regulates its meso-scale organization at the plasma membrane</article-title><source>Molecular Biology of the Cell</source><volume>31</volume><fpage>561</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1091/mbc.E18-11-0715</pub-id><pub-id pub-id-type="pmid">31577524</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sit</surname><given-names>ST</given-names></name><name><surname>Manser</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rho GTPases and their role in organizing the actin cytoskeleton</article-title><source>Journal of Cell Science</source><volume>124</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1242/jcs.064964</pub-id><pub-id pub-id-type="pmid">21321325</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Théry</surname><given-names>C</given-names></name><name><surname>Duban</surname><given-names>L</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name><name><surname>Véron</surname><given-names>P</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes</article-title><source>Nature Immunology</source><volume>3</volume><fpage>1156</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1038/ni854</pub-id><pub-id pub-id-type="pmid">12426563</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Théry</surname><given-names>C</given-names></name><name><surname>Ostrowski</surname><given-names>M</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Membrane vesicles as conveyors of immune responses</article-title><source>Nature Reviews. Immunology</source><volume>9</volume><fpage>581</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1038/nri2567</pub-id><pub-id pub-id-type="pmid">19498381</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torreno-Pina</surname><given-names>JA</given-names></name><name><surname>Castro</surname><given-names>BM</given-names></name><name><surname>Manzo</surname><given-names>C</given-names></name><name><surname>Buschow</surname><given-names>SI</given-names></name><name><surname>Cambi</surname><given-names>A</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Enhanced receptor-clathrin interactions induced by N-glycan-mediated membrane micropatterning</article-title><source>PNAS</source><volume>111</volume><fpage>11037</fpage><lpage>11042</lpage><pub-id pub-id-type="doi">10.1073/pnas.1402041111</pub-id><pub-id pub-id-type="pmid">25030450</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torreno-Pina</surname><given-names>JA</given-names></name><name><surname>Manzo</surname><given-names>C</given-names></name><name><surname>Salio</surname><given-names>M</given-names></name><name><surname>Aichinger</surname><given-names>MC</given-names></name><name><surname>Oddone</surname><given-names>A</given-names></name><name><surname>Lakadamyali</surname><given-names>M</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Cerundolo</surname><given-names>V</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells</article-title><source>PNAS</source><volume>113</volume><fpage>E772</fpage><lpage>E781</lpage><pub-id pub-id-type="doi">10.1073/pnas.1514530113</pub-id><pub-id pub-id-type="pmid">26798067</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimble</surname><given-names>WS</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Barriers to the free diffusion of proteins and lipids in the plasma membrane</article-title><source>The Journal of Cell Biology</source><volume>208</volume><fpage>259</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1083/jcb.201410071</pub-id><pub-id pub-id-type="pmid">25646084</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turville</surname><given-names>S.G</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Handley</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Pöhlmann</surname><given-names>S</given-names></name><name><surname>Doms</surname><given-names>RW</given-names></name><name><surname>Cunningham</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Diversity of receptors binding HIV on dendritic cell subsets</article-title><source>Nature Immunology</source><volume>3</volume><fpage>975</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1038/ni841</pub-id><pub-id pub-id-type="pmid">12352970</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turville</surname><given-names>SG</given-names></name><name><surname>Santos</surname><given-names>JJ</given-names></name><name><surname>Frank</surname><given-names>I</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Wilkinson</surname><given-names>J</given-names></name><name><surname>Miranda-Saksena</surname><given-names>M</given-names></name><name><surname>Dable</surname><given-names>J</given-names></name><name><surname>Stössel</surname><given-names>H</given-names></name><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Piatak</surname><given-names>M</given-names></name><name><surname>Lifson</surname><given-names>JD</given-names></name><name><surname>Pope</surname><given-names>M</given-names></name><name><surname>Cunningham</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells</article-title><source>Blood</source><volume>103</volume><fpage>2170</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-09-3129</pub-id><pub-id pub-id-type="pmid">14630806</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Zanten</surname><given-names>TS</given-names></name><name><surname>Cambi</surname><given-names>A</given-names></name><name><surname>Koopman</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>B</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion</article-title><source>PNAS</source><volume>106</volume><fpage>18557</fpage><lpage>18562</lpage><pub-id pub-id-type="doi">10.1073/pnas.0905217106</pub-id><pub-id pub-id-type="pmid">19850864</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>P</given-names></name><name><surname>Maiuri</surname><given-names>P</given-names></name><name><surname>Bretou</surname><given-names>M</given-names></name><name><surname>Sáez</surname><given-names>PJ</given-names></name><name><surname>Pierobon</surname><given-names>P</given-names></name><name><surname>Maurin</surname><given-names>M</given-names></name><name><surname>Chabaud</surname><given-names>M</given-names></name><name><surname>Lankar</surname><given-names>D</given-names></name><name><surname>Obino</surname><given-names>D</given-names></name><name><surname>Terriac</surname><given-names>E</given-names></name><name><surname>Raab</surname><given-names>M</given-names></name><name><surname>Thiam</surname><given-names>H-R</given-names></name><name><surname>Brocker</surname><given-names>T</given-names></name><name><surname>Kitchen-Goosen</surname><given-names>SM</given-names></name><name><surname>Alberts</surname><given-names>AS</given-names></name><name><surname>Sunareni</surname><given-names>P</given-names></name><name><surname>Xia</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Voituriez</surname><given-names>R</given-names></name><name><surname>Piel</surname><given-names>M</given-names></name><name><surname>Lennon-Duménil</surname><given-names>A-M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Innate control of actin nucleation determines two distinct migration behaviours in dendritic cells</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/ncb3284</pub-id><pub-id pub-id-type="pmid">26641718</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>P</given-names></name><name><surname>Barbier</surname><given-names>L</given-names></name><name><surname>Sáez</surname><given-names>PJ</given-names></name><name><surname>Piel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanisms for fast cell migration in complex environments</article-title><source>Current Opinion in Cell Biology</source><volume>48</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.04.007</pub-id><pub-id pub-id-type="pmid">28641118</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakim</surname><given-names>LM</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection</article-title><source>Nature</source><volume>471</volume><fpage>629</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1038/nature09863</pub-id><pub-id pub-id-type="pmid">21455179</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JH</given-names></name><name><surname>Janas</surname><given-names>AM</given-names></name><name><surname>Olson</surname><given-names>WJ</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells</article-title><source>Journal of Virology</source><volume>81</volume><fpage>8933</fpage><lpage>8943</lpage><pub-id pub-id-type="doi">10.1128/JVI.00878-07</pub-id><pub-id pub-id-type="pmid">17567699</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanacchi</surname><given-names>FC</given-names></name><name><surname>Manzo</surname><given-names>C</given-names></name><name><surname>Alvarez</surname><given-names>AS</given-names></name><name><surname>Derr</surname><given-names>ND</given-names></name><name><surname>Garcia-Parajo</surname><given-names>MF</given-names></name><name><surname>Lakadamyali</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A DNA origami platform for quantifying protein copy number in super-resolution</article-title><source>Nature Methods</source><volume>14</volume><fpage>789</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4342</pub-id><pub-id pub-id-type="pmid">28650478</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>B</given-names></name><name><surname>Kelly</surname><given-names>B</given-names></name><name><surname>McMillan</surname><given-names>BJ</given-names></name><name><surname>Seegar</surname><given-names>TCM</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Kruse</surname><given-names>AC</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Crystal structure of a full-length human tetraspanin reveals a cholesterol-binding pocket</article-title><source>Cell</source><volume>167</volume><fpage>1041</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.056</pub-id><pub-id pub-id-type="pmid">27881302</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78836.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.04.28.489919" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.28.489919"/></front-stub><body><p>Siglec-1 (CD169), a plasma membrane-associated sialic acid-binding lectin, has been implicated in the capture of HIV and other viruses by dendritic cells and macrophages, however, the molecular details of how HIV particles are captured by Siglec-1 are poorly understood. In this important paper, the authors use super-resolution imaging methods to analyse the cell surface distribution of Siglec-1 on immature and mature dendritic cells to study the regulation of Siglec-1 distribution by actin and regulators of actin polymerization and to understand how virus-Siglec-1 engagement leads to virus sequestration within so-called virus containing compartments. This compelling study has relevance for researchers studying the engagement of HIV and many other viruses with cells, as well as researchers interested in the mechanisms regulating receptor distribution and function on cells.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78836.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Mothes</surname><given-names>Walther</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Spearman</surname><given-names>Paul</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01hcyya48</institution-id><institution>Cincinnati Children's Hospital Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.28.489919">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.04.28.489919v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Reviewing Editor and Suzanne Pfeffer as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Walther Mothes (Reviewer #2); Paul Spearman (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Insufficient experimental detail is provided for some aspects of the paper. In particular, the information for the experiments presented in Figure 1 is currently inadequate. Please provide information on the antibodies used.</p><p>2) Antibodies are dimers and can cluster Siglec-1. It is important that single chains or Fabs are used. The preparation of monochain anti-Siglec-1 antibodies and Fab-Atto conjugates is described in the methods, but their experimental use does not appear in the results. Please present data using these monovalent reagents compared to the intact antibody and double labelling methods.</p><p>3) Please provide more information on what is referred to as 'ring-shaped compartment'. (Line 373). Is the observed labelling on the cell surface or internal? Have these structures been imaged in 3D? While I don't think it necessary to provide further details on the VCC, it is currently unclear what this pattern of staining represents.</p><p>4) Please consider and address all the comments raised by the reviewers either through the provision of additional experimental data or modifications to the text of the manuscript.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>One fundamental problem with imaging receptors in this way is knowing whether single spots correspond to individual or multiple receptor molecules. In Figure 1 the authors have gone to some lengths to understand what the labelling patterns show quantitatively. How confident can they be that the data in Figure 1B really represent 1, 2, 3, or 4 Siglec molecules? Do Siglecs form oligomers? Using two layers of antibody, as seems to be the case here, and PFA fixation, is there any possibility for antibodies to affect the distribution of Siglec-1? Such antibody-induced perturbations might be enhanced by increased Siglec-1 expression, rather than changes in the activation status of the cell.</p><p>In Materials and methods, the authors describe making monovalent anti-Siglec-1 Abs. Was Hsn 7D2 used, if so, this should be clearly stated? A gel showing the preparation should be shown in the suppl. data. I could not see where these monovalent Abs were used in the study.</p><p>Line 189, the authors claim 'the association of Siglec-1 with high-density regions of cortical actin …… was not affected by Arp2/3 inhibition' – although analysis of just the cortical regions of the cell may suggest little effect of CK666, Siglec-1 labelling over the middle of the cell suggests there is an effect of this inhibitor (Figure 2C). Moreover, it seems the ROI's indicated in these images differ; the top two being over actin-rich areas and the bottom SMIFH2 region being over an actin-depleted area. How were ROIs selected? Do the authors have controls to ensure CK666 and SMIFH2 had the expected effects on ARP2/3, formins, and actin?</p><p>Line 197: in this paragraph, the authors verify the effect of SMIFH2 on Siglec-1 using SPT; did they also do SPT with CK666 treated cells?</p><p>The methods for imaging and image analysis are presented in detail, but there are some aspects of the methods that need to be better explained. E.g., Line 547 refers to 'viral stocks' but the methods describe only the production of VLPs – these are not viruses. The text in this section and the relevant Results section (pages 10/11) need to be changed to avoid suggesting that an infectious virus was used. The VLPs were made using Gag and Env plasmids. Do the authors know if Env is present in the VLPs? Alternatively, do they know whether the results observed with VLPs are influenced at all by Env? Did they use VLPs lacking Env and, if so, what were the results? If Env is incorporated into the VLPs it is likely to be organised differently from that on mature virions as the lack of protease activity in the VLPs would prevent maturation-associated changes in Env distribution.</p><p>Can the authors indicate how the concentrations of GM-1 used in LUVs compare to those of the VLPs used in these experiments?</p><p>Line 373: can the authors be clearer about what they call a 'ring-shaped compartment'. Is the observed labelling on the cell surface or internal? Have these structures been imaged in 3D?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Insufficient experimental detail is provided for Figure 1. What anti-Siglec-1 antibodies, and what secondary antibodies were used? Antibodies are dimers and can cluster Siglec-1. It is important that single chains or Fabs are used. Monochain anti-Siglec-1 antibodies and Fab-Atto conjugates are listed in the methods, but the actual experimental conditions for Figure 1 are neither mentioned in the text nor in the figure legend.</p><p>How is the analysis of actin affected by changes in cell shape, which are dramatic in the transition from iDCs to mDCs?</p><p>The paper is narrowly focused on DCs but macrophages express CD169 and trans-infected permissive cells, particularly in vivo and mechanistic studies relevant to the current study like the formation of virus containing vacuoles in a Siglec-1 dependent manner should be cited and discussed, e.g. PMID: 28129379.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The only direct suggestion for this work is to better define the VCC in the context of the experiments shown, using other VCC markers and indicating the cellular position of the VCC (ie internal or merely concentrated virions on the surface). I don't think you can call something a VCC when it is concentrated VLP + Siglec clustering that has not undergone invagination/internalization and is characterized also by typical VCC markers.</p><p>Some biological significance to trans-infection events could be easily added to this report, showing that disruption of formin or RhoA pathways prevents trans-infection. This is not really necessary in my opinion for the current report but would boost overall significance.</p><p>I would like to see additional comments on the mechanism and significance of Siglec-1 capture and movement on the apical vs basal cell surface. The manuscript reads as if VLPs are all concentrated on the basal surface, yet VLPs are often captured on the exposed apical surface by Siglec-1. For the images shown, especially where there is a ring of Siglec or Siglec and VLPs, it would help to show a z-series or 3D view to see where this ring is. Is it around the cell soma but on the apical surface, or really on the basal surface?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78836.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>One fundamental problem with imaging receptors in this way is knowing whether single spots correspond to individual or multiple receptor molecules. In Figure 1 the authors have gone to some lengths to understand what the labelling patterns show quantitatively. How confident can they be that the data in Figure 1B really represent 1, 2, 3, or 4 Siglec molecules? Do Siglecs form oligomers? Using two layers of antibody, as seems to be the case here, and PFA fixation, is there any possibility for antibodies to affect the distribution of Siglec-1? Such antibody-induced perturbations might be enhanced by increased Siglec-1 expression, rather than changes in the activation status of the cell.</p></disp-quote><p>We appreciate the concern of the reviewer. Indeed the experiments shown in Figure 1 have been performed using secondary antibody labeling which is the standard for super-resolution STED imaging. Obviously, labeling has been performed after fixing the cells with 4% PFA which has been shown by multiple groups (including ours) to fully immobilize receptors on the cell membrane (Leyton-Puig et al., <italic>Methods and Tech.</italic> 2016; Bakker et al., <italic>PNAS</italic> 2012; Torreno-Pina et al., <italic>PNAS</italic> 2014). In these conditions, the possibility of artefactual clustering is negligible. Having said that, we agree with the reviewer that in conditions where the expression level of the receptors is very high, potential Ab-induced perturbations might still occur. Thus, to fully rule out potential artifacts due to Siglec-1 labeling or fixation by PFA, we performed two different control experiments; (1) we used single-chain antibodies (Abs.) for labeling Siglec-1 in cells fixed with 4% PFA (as used in our original submission) and, (2) we use single-chain Abs. on cells fixed with 1% PFA + 0.2% GA (glutaraldehyde). Analysis on multiple STED images in these two types of control experiments showed no difference in terms of nanoclustering capacity of Siglec-1 on activated DCs as compared to the full Ab labeling, regardless of the fixation protocol. Thus, these controls rule out any potential artefacts due to labeling conditions or sample fixation. We have now included these control experiments as Figure 1—figure supplement 1E-I, Figure 1—figure supplement 1-source data 1 and Figure 1—figure supplement 1-source data 2 and added a paragraph in the revised manuscript regarding these controls and results (see page 5-6).</p><disp-quote content-type="editor-comment"><p>In Materials and methods, the authors describe making monovalent anti-Siglec-1 Abs. Was Hsn 7D2 used, if so, this should be clearly stated? A gel showing the preparation should be shown in the suppl. data. I could not see where these monovalent Abs were used in the study.</p></disp-quote><p>We apologize for omitting this information in the original manuscript. Single-chain Abs were used for all the single molecule live imaging experiments (Figure 1E-J; Figure 2J-L). Since direct fluorophore labeling of the single chains was very inefficient and resulted in weak signals, we used Fab-Atto488 anti-mouse to label the single-chains Abs. And yes, we used a mouse monoclonal antibody to Siglec-1 (Hsn 7D2), obtained from Abcam. We have now included all the relevant information at the appropriate parts in the manuscript as well as included the gel data on the full and single chains (see Figure 1—figure supplement 1E and Figure 1—figure supplement 1-source data 1).</p><disp-quote content-type="editor-comment"><p>Line 189, the authors claim 'the association of Siglec-1 with high-density regions of cortical actin …… was not affected by Arp2/3 inhibition' – although analysis of just the cortical regions of the cell may suggest little effect of CK666, Siglec-1 labelling over the middle of the cell suggests there is an effect of this inhibitor (Figure 2C). Moreover, it seems the ROI's indicated in these images differ; the top two being over actin-rich areas and the bottom SMIFH2 region being over an actin-depleted area. How were ROIs selected? Do the authors have controls to ensure CK666 and SMIFH2 had the expected effects on ARP2/3, formins, and actin?</p></disp-quote><p>Although the representative images shown in Figure 2C might indeed suggest there is also an effect of CK666, our observations are based on the statistical analysis over multiple and random ROIs per cell, and performed on at least 10 cells per condition (control, CK666 treated and SMIFH2 treated) and for different donors. As such, the analysis is extremely robust. To avoid any confusion to the reader, we have now slightly modified the lowest panel of Figure 2C and provide an enlarged view on an actin-rich region, similar to the control and CK666 treated samples. Although we did not perform specific controls of CK666 and SMIFH2 regarding the expected effects on Arp2/3 and formins respectively, we and many others in the field have routinely used these treatments to perturb specific components of actin polymerization (Henson et al. <italic>Mol. Biol. Cell</italic> 2015, Freeman et al. <italic>Cell</italic> 2018, Sil et al. <italic>Mol. Biol. Cell</italic> 2019; Nishimura et al. <italic>J. Cell Sci.</italic> 2021, amongst others).</p><disp-quote content-type="editor-comment"><p>Line 197: in this paragraph, the authors verify the effect of SMIFH2 on Siglec-1 using SPT; did they also do SPT with CK666 treated cells?</p></disp-quote><p>SPT experiments including thorough data analysis is quite demanding and laborious. Therefore, considering the large amount of different experiments reported in the manuscript and the fact that we did not observe statistical differences upon CK666 treatment on the organization of Siglec-1 by means of STED, we exclusively focused on SPT experiments and their analysis upon SMIFH2 perturbation. Although we could perform SPT experiments on CK666 treated cells, we believe that they would not provide additional insights. Instead, during the course of our research we considered more relevant to study the relationship between formins and Siglec-1 nanoscale organization in a physiological situation in which different types of actin pools simultaneously occur at specific regions of the plasma membrane. As shown and quantified in the <italic>Figure 2—figure supplement 1F-I</italic> and <italic>Figure 2—figure supplement 1-source data 1</italic>, Siglec-1 was remarkably enriched at the cell rear, where it is known that actin polarization is mainly formin-dependent (Lämmermann and Sixt, <italic>Curr Opin Cell Biol</italic>. 2009; Paluch et al <italic>Annu Rev Cell Dev Biol</italic>. 2016; Vargas et al. <italic>Nat Cell Biol.</italic> 2016). Moreover, a significant enhancement of Siglec-1 nanoclusters was detected at the cell rear as compared to the lamellipodium at the front which is mainly dependent on Arp2/3 branched actin.</p><disp-quote content-type="editor-comment"><p>The methods for imaging and image analysis are presented in detail, but there are some aspects of the methods that need to be better explained. E.g., Line 547 refers to 'viral stocks' but the methods describe only the production of VLPs – these are not viruses. The text in this section and the relevant Results section (pages 10/11) need to be changed to avoid suggesting that an infectious virus was used. The VLPs were made using Gag and Env plasmids. Do the authors know if Env is present in the VLPs? Alternatively, do they know whether the results observed with VLPs are influenced at all by Env? Did they use VLPs lacking Env and, if so, what were the results? If Env is incorporated into the VLPs it is likely to be organised differently from that on mature virions as the lack of protease activity in the VLPs would prevent maturation-associated changes in Env distribution.</p></disp-quote><p>We apologize for the confusion. The methods have now been changed to “Viral like particle stock production” and also in the indicated pages.</p><p>Regarding the presence of Env in the VLPs: the co-transfection of HIV-1 Gag plasmids along with an HIV-1 envelope plasmid to produce a pseudotyped VLP is well established in the literature. Although we have not directly checked for the presence of the envelope glycoproteins in these VLPs, we have used the same methodology to pseudotype a single-cycle infectious HIV-1-δ-envelope construct that contains a luciferase reporter gene. These single cycle HIV-1 pseudotyped viral particles effectively infect target cells, clearly showing that envelopes are incorporated into these particles allowing for productive infection (Izquierdo-Useros et al. <italic>J. Virol</italic> 2007).</p><p>Regarding the potential influence of Env: We and others have extensively described that the envelope glycoprotein of HIV-1 is not required for the viral recognition mediated by Siglec-1 (Izquierdo-Useros et al. <italic>PloS Biol</italic> 2012; Puryear et al. <italic>PNAS</italic> 2012 and <italic>PLoS Pathog</italic> 2013) as we also confirm in this manuscript using LUVs lacking this molecule. Indeed, prior data from our group already showed how HIV-1 VLPs lacking the envelope glycoprotein and HIV-1wt viruses accumulate within the same virus containing compartment in mature dendritic cells (Izquierdo-Useros et al. <italic>Blood</italic> 2009). That is also the reason why this receptor is able to interact with many different enveloped viruses that display very distinct envelope glycoproteins, such as Ebola Virus, Marburg Virus, or even SARS-CoV-2, that contain sialylated gangliosides (Perez-Zsolt et al. <italic>Nat Microbiol</italic> 2019 and <italic>Cell Mol Immunol</italic> 2021). In the particular case of HIV-1, it has been shown that only 14 +/- 7 envelope trimers are incorporated per virion (Zhu et al. <italic>Nature</italic> 2006). This incorporation into the VLPs is not dependent on the protease activity, which acts internally inside the viral particle to cleave gag polyproteins and release matrix, capsid, nucleocapsid and p6 subunits. However, as the reviewer mentions, in mature HIV-1 particles, the envelope glycoprotein trimers are able to diffuse and cluster together, favoring the infectious process of the virus, which is not the focus of our study.</p><disp-quote content-type="editor-comment"><p>Can the authors indicate how the concentrations of GM-1 used in LUVs compare to those of the VLPs used in these experiments?</p></disp-quote><p>Lipidomic analysis of HIV-1 membranes estimated that there are 300,000 lipids per viral particle and 12,000 GM3 molecules per virion (Brügger et al. <italic>PNAS</italic> 2006; Chan et al <italic>J Virol</italic> 2008). Other gangliosides such as GM1 are also present in HIV-1 membranes (Izquierdo-Useros et al. <italic>PloS Biol</italic> 2012) but they remain to be accurately quantified. Taking into consideration only those calculations that have been accurately performed, 12,000 gangliosides constitute approximately 4% of the total lipid molecules present in one virus. That is in fact the reason why we have used a 4 % of ganglioside content to mimic the lipid composition of HIV-1 or VLPs. The presence of thousands of sialyllactose-containing gangliosides in the viral membrane is expected to support high-avidity interactions with clusters of Siglec1 receptors, as we show here by decreasing the percentage of ganglioside content in the LUVs used, which alters LUV recognition. We have now added this information in the Materials and Methods section and include additional references regarding the number of gangliosides in the viral membrane (see page 21).</p><disp-quote content-type="editor-comment"><p>Line 373: can the authors be clearer about what they call a 'ring-shaped compartment'. Is the observed labelling on the cell surface or internal? Have these structures been imaged in 3D?</p></disp-quote><p>By “ring-shaped compartment” we refer to the area of the cell a few microns above the basal membrane being physically constrained by the enrichment of actin, Siglec-1 and VLPs (as shown in Figure 6A at 30 min of VLPs or 4% GM-1 LUVs incubation). The observed labeling of Siglec-1 and VLPs (or LUVs) is on the surface of the cells (not internal) imaged by 3D confocal imaging at different z positions. The images were obtained on fixed cells labeled for actin, Siglec-1 and VLPs (or LUVs), and by performing 3D stacks by confocal microscopy. As explained in the Material and Methods section the whole surface of cells was covered in stacks of 10-15 images from the bottom to the top. We applied intensity thresholds for each staining and calculated the mean intensity values in axial planes of 1.5 µm. To measure the area of cells at different axial planes after VLP/LUV capture, we delimited the edges of cells stained with SiRactin applying a binary mask for each plane and quantified the area enclosed in such perimeter. We have now clarified better the different panels of Figure 6 where the ring-shaped regions are shown.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Insufficient experimental detail is provided for Figure 1. What anti-Siglec-1 antibodies, and what secondary antibodies were used? Antibodies are dimers and can cluster Siglec-1. It is important that single chains or Fabs are used. Monochain anti-Siglec-1 antibodies and Fab-Atto conjugates are listed in the methods, but the actual experimental conditions for Figure 1 are neither mentioned in the text nor in the figure legend.</p></disp-quote><p>We apologize for the lack of clarity regarding the labeling strategies used for the different imaging experiments reported in the manuscript. For the data shown in Figure 1A-D we used primary and secondary Abs. and performed labeling after fixing the cells, as it is the standard method for STED imaging. Still, we acknowledge that in conditions where the expression of receptors is high, such as in the case of Siglec-1 in mDCs, this labeling strategy might introduce potential perturbations on the organization of the receptors. Therefore, and following also the request of reviewer 1, we performed control experiments by labeling the cells using single-chain Abs. and under different fixation conditions. These new results showed no difference in terms of nanoclustering capacity of Siglec-1 on activated DCs as compared to the full Ab labeling and regardless of the fixation method. Overall, these controls rule out any potential artefacts due to labeling conditions or sample fixation. The results are now included in <italic>Figure 1—figure supplement 1E-I</italic> together with the corresponding source data, and mentioned in the main text of the manuscript. In addition, we also specify now in the caption of Figure 1 how the labeling of Siglec-1 for STED imaging has been performed. In addition, in the case of the single molecule imaging data obtained in living cells and shown in Figures 1E-J and Figures 2J-L, we have used single-chain Abs. labeled with Fab-Atto488. We have also included this information in the caption of Figure 1.</p><disp-quote content-type="editor-comment"><p>How is the analysis of actin affected by changes in cell shape, which are dramatic in the transition from iDCs to mDCs?</p></disp-quote><p>In fact, we did not perform a detail analysis on actin re-organization since as the reviewer mentions, there are major changes in cell shape in the transition from iDCs to mDCs. Instead, we focused our studies on assessing the location on the plasma membrane where siglec-1 confinement and nanoclustering was more prominent, in relation to the intensity of the actin signal.</p><disp-quote content-type="editor-comment"><p>The paper is narrowly focused on DCs but macrophages express CD169 and trans-infected permissive cells, particularly in vivo and mechanistic studies relevant to the current study like the formation of virus containing vacuoles in a Siglec-1 dependent manner should be cited and discussed, e.g. PMID: 28129379.</p></disp-quote><p>We thank the reviewer for this suggestion and have now incorporated a small paragraph in the discussion as well as providing the reference (see page 19).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The only direct suggestion for this work is to better define the VCC in the context of the experiments shown, using other VCC markers and indicating the cellular position of the VCC (ie internal or merely concentrated virions on the surface). I don't think you can call something a VCC when it is concentrated VLP + Siglec clustering that has not undergone invagination/internalization and is characterized also by typical VCC markers.</p></disp-quote><p>As mentioned above, our study provides important insights into the earliest events that later lead to VCC formation. Thus, we do not focus on the actual VCC in the current manuscript since it has been extensively studied by others (and us) in the past. This is the reason why we always refer to a “ring-shaped compartment”, i.e., the area of the cell above the basal membrane being physically constrained by the enrichment of actin, Siglec-1 and VLPs (as shown in Figure 6A at 30 min of VLPs or 4% GM-1-LUVs incubation), rather than to the VCC. We believe that the formation of this ring-compartment precedes the final formation of the VCC. To avoid any misunderstanding in the manuscript we have now clarified the sentences that relate to the VCC, indicating that the formation of the VCC will eventually occur at later stages.</p><disp-quote content-type="editor-comment"><p>Some biological significance to trans-infection events could be easily added to this report, showing that disruption of formin or RhoA pathways prevents trans-infection. This is not really necessary in my opinion for the current report but would boost overall significance.</p><p>I would like to see additional comments on the mechanism and significance of Siglec-1 capture and movement on the apical vs basal cell surface. The manuscript reads as if VLPs are all concentrated on the basal surface, yet VLPs are often captured on the exposed apical surface by Siglec-1. For the images shown, especially where there is a ring of Siglec or Siglec and VLPs, it would help to show a z-series or 3D view to see where this ring is. Is it around the cell soma but on the apical surface, or really on the basal surface?</p></disp-quote><p>We apologize for the confusion as indeed the ring is not formed at the basal surface but a few microns above it. To clarify: the images shown in Figure 6A correspond to intensity projections of 3D-confocal images taken at every 1.5 µm from the basal to the apical membrane (between 10-15 stacks per image). On the bottom part of Figure 6A we show the outlined perimeter obtained from each stack, color coded according to the axial position of each plane with respect to the basal membrane. Visually, the highest constriction occurs at a plane around 4-6 µm above the basal surface. This is robustly quantified in <italic>Figure 6—figure supplement 1A,B</italic> and associated source data where we show that the highest colocalization between Siglec-1, actin and VLPs (or LUVs) occurs at axial distances around 4-6 µm <italic>above</italic> the basal membrane. We have now clarified the main text and the caption of Figure 6 to indicate better where the region of highest constriction and recruitment of Siglec-1, actin and VLPs (or LUVs) occurs.</p></body></sub-article></article>